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Abstract
Bone-marrow mesenchymal stem cells (BMSC) are considered the gold standard for use in tissue regeneration among
mesenchymal stem cells (MSC). The abundance and ease of harvest make the adipose-derived stem cells (ASC) an attractive
alternative to BMSC. The aim of the present study was to compare the transcriptome of ASC and BMSC, respectively isolated
from subcutaneous adipose tissue and femur of 3 adult pigs, during in vitro osteogenic and adipogenic differentiation for
up to four weeks. At 0, 2, 7, and 21 days of differentiation RNA was extracted for microarray analysis. A False Discovery Rate
#0.05 for overall interactions effect and P,0.001 between comparisons were used to determine differentially expressed
genes (DEG). Ingenuity Pathway Analysis and DAVID performed the functional analysis of the DEG. Functional analysis of
highest expressed genes in MSC and genes more expressed in MSC vs. fully differentiated tissues indicated low immunity
and high angiogenic capacity. Only 64 genes were differentially expressed between ASC and BMSC before differentiation.
The functional analysis uncovered a potential larger angiogenic, osteogenic, migration, and neurogenic capacity in BMSC
and myogenic capacity in ASC. Less than 200 DEG were uncovered between ASC and BMSC during differentiation.
Functional analysis also revealed an overall greater lipid metabolism in ASC, while BMSC had a greater cell growth and
proliferation. The time course transcriptomic comparison between differentiation types uncovered ,500 DEG necessary to
determine cell fate. The functional analysis indicated that osteogenesis had a larger cell proliferation and cytoskeleton
organization with a crucial role of G-proteins. Adipogenesis was driven by PPAR signaling and had greater angiogenesis,
lipid metabolism, migration, and tumorigenesis capacity. Overall the data indicated that the transcriptome of the two MSC
is relatively similar across the conditions studied. In addition, functional analysis data might indicate differences in
therapeutic application.
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Introduction
Reports of successful use of bone marrow derived mesenchymal
stem cells (BMSC) in tissue engineering applications and disease
treatments [1,2], in addition to concerns about the use of
embryonic stem cells, have stimulated increased interest in the
use of adult stem cells for therapeutic purposes. Interestingly,
among adult stem cells, the mesenchymal stem cells (MSC) are
featured with several therapeutic properties, which make them
excellent candidates for tissue replacement therapies. The MSC
are able to differentiate into multiple cell lineages [3], secrete
several factors (growth factors and cytokines) with important
functions in tissue regeneration [4], are immune privileged [5],
and secrete immunomodulatory factors [6,7].
Mesenchymal stem cells were originally isolated from bone
marrow [8], but they appear to be present in many tissues. One of
the most interesting tissues for the isolation of MSC is adipose.
The quantity and accessibility of subcutaneous adipose tissue in
humans makes it an attractive alternative to bone marrow as a
source of adult stem cells [9–11]. Reports of successful isolation
and differentiation of adult stem cells derived from human adipose
tissue have stimulated further studies regarding the ubiquity,
similarity, and multipotency of these cells in comparison with
BMSC [11–15].
The human-derived adipose stem cells can be easily studied in
vitro but, for the in vivo studies, an appropriate animal model is
needed. The pig is an ideal animal model for initial studies
exploring human therapeutic applications. For instance, pigs are
immunologically and physiologically more similar to humans than
other non-primate species [16]. Previous in vitro studies reported in
the scientific literature, or done in our laboratory, demonstrated
that porcine adipose derived stem cells (ASC) can be easily
harvested, isolated, expanded and differentiated in vitro
[11,13,17,18].
We have previously characterized the morphological features of
porcine BMSC and ASC during adipogenic and osteogenic
differentiation [18]. That study clearly demonstrated that both
MSC are able to differentiate into adipocytes and osteocytes, but
with some morphological differences. During the osteogenic
differentiation large nodules are formed by ASC in contrast to a
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analyzed the temporal expression of few osteogenic and adipo-
genic markers. In a further study, using the same conditions except
that the MSC were cultivated in 3D hydrogel, no morphological
differences were observed in the osteogenic differentiation between
ASC and BMSC [17].
Some differences at the transcription level [19] and differenti-
ation capacity [20] between BMSC and ASC have been previously
reported in humans and mice. Besides those reported differences
and the morphological differences seen in our 2D study during the
osteogenic differentiation [18], the two MSC seem to be nearly
identical when considered in the context of clinical applications
[19,21]. However, a more in depth comparison between BMSC
and ASC is required in order to discover potential differences
useful in a clinical setting. Analysis of the transcriptome can
uncover main genes and associated functions that participate in
determining the potential differences between the two MSC
during differentiation. Few studies have been performed with
human MSC where a transcriptomics comparison between BMSC
and ASC has been reported, and none of those were longitudinal
studies [19,22].
The aim of the present study was to compare the transcriptome
of porcine ASC and BMSC prior and during in vitro osteogenic and
adipogenic differentiation. The results from this study uncovered
that the transcriptome of the two MSC were similar before
differentiation and relatively similar during differentiation. Func-
tional analysis revealed an overall greater lipid metabolism in
ASC, while BMSC had a greater cell growth and proliferation
during differentiation. A relatively large number of genes
differentially expressed were observed between differentiation
types with osteogenesis featured by large cell proliferation, while
adipogenesis was driven by PPAR signaling and was featured by
an active angiogenesis, lipid metabolism, and migration.
Results and Discussion
Reported in the present manuscript are main findings.
Additional results and discussion are reported in file S1 and
complete dataset in file S2.
Highly abundant transcripts and MSC vs. fully
differentiated tissues
The complete results from the highly expressed genes in MSC
and DEG between MSC and fully differentiated cells are discussed
in details in file S1 and reported in file S3 and S4. Among the most
interesting findings were that highly abundant transcripts in MSC
were significantly enriched in functions related to protein synthesis
and with roles in extracellular matrix formation, differentiation,
immune suppression, and cell cycle regulation. In addition, the
comparison between MSC and fully differentiated tissues indicated
that genes low expressed in MSC vs. differentiated tissues
significantly enriched functions related to immune systems
response including also major histocompatibility complex. All of
these data reinforce the fact that MSC are immune-privileged, and
this appears to be a feature of the MSC and likely regulated at the
transcriptomic level.
Transcriptome comparison prior to in vitro differentiation
Correlation analysis. The coefficient of correlation prior to
differentiation (dd0) between the complete measured
transcriptome of ASC and BMSC was 0.79 (p,0.0001; Figure 1
and Table S1) while the correlation among DEG was 0.63. When
correlations between the transcriptome of ASC and BMSC at dd0
were run for each pig (Table S1) we observed variations among
animals (r from 0.70 to 0.90). A similar animal variation was
observed in the correlation between the transcriptome of ASC and
BMSC during differentiation (Table S1). The three pigs used were
of the same breed, same age, similar weight, and were raised in the
same environment; in addition, the protocol for stem cells
extraction and culture was identical between the three pigs. The
inter-animal variation observed might be explained by animal
genetics or by epigenetics factors. To our knowledge there is not
available information in the literature about transcriptome
correlation among ASC and BMSC in pigs. However, our
observation appears to be in contradiction with previously
reported data of high similarity between samples found in the
transcriptome correlation between ASC and BMSC in humans
using a relatively small microarray dataset [19]. The latter
observation is also confirmed by analysis from another large
microarray dataset [22], where the correlations ranged from 0.954
to 0.963 (Figure S1). Those data are surprising considering the
large genetic and epigenetic variation among humans compared to
specific pig breeds.
Number of DEG. Using a post-hoc correction of P,0.001,
65 DEG (64 unique annotated genes or 0.5% of all oligos coding
for genes in array) were found between BMSC and ASC at dd0
Figure 1. Overall correlation of the transcriptome between ASC
and BMSC. Correlation of the transcriptome between ASC and BMSC
during the whole experiment (top panel; r=0.78; p,0.0001) or prior
differentiation (bottom panel; r=0.79; p,0.0001). This analysis high-
lights the large similarity between the two cell types both prior
differentiation and during osteogenic or adipogenic differentiation.
doi:10.1371/journal.pone.0032481.g001
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(see file S5, Sheet 1). The percentage of DEG compared to the
measured transcriptome between the two cell types found in this
experiment is lower than that previously reported in humans [19].
Microfibrillar associated protein 5 (17-fold; MFAP5), fibulin 2 (13-
fold; FBLN2), periostin or osteoblast specific factor (8-fold;
POSTN), secreted frizzled-related protein 2 (7-fold; SFRP2), and
RNA 28S ribosomal 1 (7-fold; RN28S1) were the genes with .4-
fold greater expression in ASC compared to BMSC. Interestingly
the MFAP5, FBLN2, and POSTN are all extracellular matrix
proteins, with specific roles in bone formation [23–25], and
POSTN appears to play a role in tumorigenesis [25]. The SFRP2 is
a modulator of Wnt signaling pathways and appears to induce,
through the signaling of the Wnt pathway, cell growth [26] and
osteogenesis [27]. Overall, the data suggest a specific osteogenic-
signature in undifferentiated ASC compared to BMSC.
Osteopontin (7-fold; SPP1) was the only gene expressed at a
level .4-fold in BMSC vs. ASC. The latter observation was
confirmed by qPCR analysis (file S2). SPP1 has been first isolated
from bone where it is highly abundant and participates actively in
osteogenesis [28]. The significance of the higher abundance of
SPP1 in BMSC compared to ASC is not clear. Other genes over-
expressed (.2-fold) in BMSC vs. ASC were: myelin protein zero
(MPZ), high mobility group AT-hook 1 (HMGA1), vascular
endothelial growth factor A (VEGFA), fibronectin type III
domain containing 3A (FNDC3A), and fibronectin 1 (FN1). The
MPZ has important roles in myelination of peripheral nerves and
cell adhesion [29]. The HMGA1 is highly expressed in
adenocarcinoma and appears to increase cancer invasiveness
[30]. The VEGFA is a pivotal factor in angiogenesis [31].
Fibronectin proteins have an important role in extracellular
matrix formation, especially during osteogenesis [32]. Overall, the
genes with greater expression in BMSC vs. ASC suggest the former
has a greater capacity for adhesion and migration into the tissues.
Moreover, if VEGFA is elevated in BMSC in vivo compared to
ASC, then BMSC may have a greater angiogenic capacity
compared to ASC, which appears to challenge the well-known
higher angiogenic capacity of adipose tissue compared to BMSC
[21,33]. In accordance with our findings, it has been demonstrated
that BMSC have angiogenic capacity, at least in tumors [34], and
VEGF has been reported to be more expressed in BMSC
compared to ASC in humans [19]. On the other hand, we have
observed a larger expression of VEGFA in ASC vs. BMSC during
adipogenesis (see below).
A direct comparison of the gene expression in this current study
was made with genes previously reported [19] to have significantly
higher expression in human ASC vs. BMSC (8 genes) and in
BMSC vs. ASC (29 genes). Among the 37 genes reported in the
human study only 4 were present as DEG in our analysis, with
VEGFA and wingless-type MMTV integration site family member
5A (WTN5) confirmed to be more expressed in BMSC vs. ASC. In
addition, the analysis confirmed a greater expression of SFRP2 in
ASC vs. BMSC. The fibronectin 1 was among the genes with a
larger expression in ASC vs. BMSC in the human comparison [19]
but was among the genes with greater expression in BMSC vs.
ASC in the current study of porcine cells. The different results may
highlight a likely species-specific difference.
Functional enrichment analysis. Several functions were
identified by using IPA with a minimum of 2 genes as
significantly overrepresented in DEG between BMSC and ASC
at dd0 (Table 1; supplementary details in file S5). Several
functions were found significantly enriched in the 24 DEG more
expressed in BMSC vs. ASC, and only few were enriched in the
40 DEG more expressed in ASC vs. BMSC. It is interesting that
most of the DEG in the significantly enriched functions were
the ones with the greatest difference in expression between the
types of cells, particularly for the genes more expressed in
BMSC vs. ASC. This may suggest that the enriched functions
were highly impacted.
The number of genes of significant enriched functions in DEG
more expressed in ASC compared to BMSC was very low (2 and
3, see Table 1), but the number of genes was relatively low also for
enriched functions in additional comparisons. Thus, the interpre-
tation of those functions needs to be taken cum grano salis. The
enrichment analysis is highly dependent on the dimension of the
gene list [35]: smaller is the gene list higher is the likelihood of
finding significant enriched functions. Despite this limitation, and
in order to be consistent, we have set for all the comparisons a
threshold of significance for discussion of $2 genes per function, as
for the default in DAVID [36].
Table 1. Functions significantly enriched (Benjamini-Hochberg FDR #0.05) in DEG between ASC and BMSC at dd0 (or prior
differentiation).
Cell type
1 Category P-value
2 # Genes Effect on function (all induced)
3
ASC Skeletal and Muscular System Development
and Function
0.023 2 Myogenesis
Tissue Development 0.023 3 Tissue development
BMSC Cellular Movement 0.004 5 Cell migration and invasion
Immune Cell Trafficking 0.004 9 Migration of immune cells and activation of T-lymphocytes
Cell-To-Cell Signaling and Interaction 0.006 8 Activation of T-lymphocytes and adhesion of fibroblasts
Tissue Development 0.006 3 Cell adhesion
Connective Tissue Development and Function 0.006 6 Adhesion and growth of fibroblasts
Cellular Assembly and Organization 0.006 13 Outgrowth of neurites, quantity of focal adhesion, and
rearrangement of the cytoskeleton
1ASC denotes genes more expressed in ASC vs. BMSC while BMSC denotes genes more expressed in BMSC vs. ASC.
2The P-value denotes the Benjamini-Hochberg FDR corrected P-value as provided by Ingenuity Pathway Analysis. Additional functions significant with a non-corrected
P-value #0.05 are reported in online file S5.
3The effect on function is estimated by the ‘‘effect on function’’ option in IPA using criteria as described in supplementary Materials and Methods in file S1. The ‘‘all
induced’’ indicates that all the reported functions were overall induced in the DEG more expressed in one stem cell type vs. the other.
doi:10.1371/journal.pone.0032481.t001
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a high enrichment in DEG more expressed in ASC vs. BMSC of
terms related to tissue development. In particular, the analysis of
effect on functions in IPA (file S5, Sheets 4 and 5) identified
myogenesis as the most enriched and induced function (Table 1).
Functions enriched significantly among the genes over-expressed
in BMSC vs. ASC included cell movement and migration, bone
formation, angiogenesis (e.g., cardiovascular system development),
and nervous system development (Table 1 and file S5, Sheets 8).
Moreover, the analysis uncovered a significant enrichment of
functions related to metabolism among the DEG that were more
expressed in BMSC vs. ASC (e.g., carbohydrate, gene expression,
molecular transport, DNA metabolism, and protein synthesis).
The functional analysis suggested an overall greater capacity of the
undifferentiated BMSC vs. undifferentiated ASC for migration,
cell adhesion, inflammatory response, and binding of carbohy-
drates (file S5, Sheet 9). There were not significantly enriched
pathways in IPA analysis in the two gene lists.
The results from DAVID confirmed (but only with an EASE
score ,0.1) the enrichment of genes involved with muscle
development in DEG with greater expression in ASC vs. BMSC
(file S5, Sheet 2 and 3), and enrichment of genes involved in
metabolism (particularly nitrogen and purine metabolism and
secretion) and adhesion in DEG with greater expression in BMSC
vs. ASC (file S5, Sheet 6 and 7). The DAVID analysis additionally
uncovered among the most enriched terms in DEG more
expressed in ASC vs. BMSC extracellular matrix, actin binding,
and several TFBS (file S5, Sheets 2 and 3). Among the latter, the
most enriched were BRACH, which represents the site for the
binding of Brachyury protein (29 DEG had binding motifs able to
bind the TF), the heat shock transcription factor 2 (HSF2; 24 DEG
with binding motifs for the TF), the sex determining region Y
(SRY; 23 DEG with binding motifs for the TF), and regulatory
factor 61 (RFX1; 30 DEG with binding motifs for the TF). The
BRACH protein has been shown to be important during the
differentiation in chondrocytes of MSC [37]. The HSF2 protein is
important in neuronal development, particularly in cortex
development [38,39]. The SRY is important in the determination
and development of testis [40]. The RFX1 is known to regulate
MHC class II expression [41], to affect spermatogenesis [42], and
to indirectly increase neuronal differentiation through induction of
FGF1 expression [43]. These findings suggest a higher chondro-
genic, neurogenic, and spermatogenic differentiation capacity of
the ASC compared to BMSC. Indeed it has been shown that both
MSC are able to restore male fertility [44], differentiate to
chondrocytes [45], or induce differentiation of neurogenic lineages
[46,47] likely through release of paracrine factors.
The most enriched terms from the DAVID analysis of the DEG
with higher expression in BMSC vs. ASC at dd0 were related to
nitrogen compound metabolism, vesicle transport, fibronectin, and
bone resorption and remodeling (file S5, Sheet 6 and 7). However,
the number of genes was low (from 2 to 5) to provide a biologically
relevant conclusion. The most enriched TFBS was ARP1 with 15
DEG presenting binding sites able to bind the TF. This TF is
known to be highly expressed in human BMSC [48] with multiple
functions. Some of those functions, for instance, are involved in
liver development [49], brain development [50], and normal
embryonic development [51]. Those data indicate that BMSC are
probably more prone to differentiate into liver or pancreas
compared to ASC. However, this inferred conclusion needs to be
verified by in vitro and/or in vivo data.
Overall data indicated that the two undifferentiated MSC have
substantial similarity at the transcriptome level, with ASC having a
greater expression of most DEG compared to BMSC. The
transcriptome differences between these MSC may relate to a
slight diversity in differentiation capacity.
Overall DEG between ASC and BMSC
Details of results and discussion of DEG between ASC and
BMSC during the entire experiment (cell type effect with FDR P-
value #0.05) with relative functional analysis are reported in file
S1, S7 and S9.
Transcriptome comparison between in vitro osteogenic
and adipogenic differentiation in ASC and BMSC
Correlation analysis. The overall measured transcriptome
correlation between the osteogenic and adipogenic differentiation
was positive (0.78; P-value ,0.0001). This value was surprisingly
not different than when the same analysis was run for the dd0
only. Correlation considering only the DEG with overall FDR
#0.05 was 0.70. When the correlation was run for each cell type
the ASC showed a higher correlation (r=0.80) compared to
BMSC (r=0.74). Among time points, day of differentiation (dd) 7
had the lowest correlation. There was a variation in transcriptome
correlation of osteogenic and adipogenic differentiation among
animals (Table S1).
Number of DEG. The number of DEG between the
adipogenic and osteogenic differentiation was relatively low in
ASC, with the lowest number of DEG observed at dd2, followed
by an increase up to dd21 (Figure 2). The number of DEG that
had greater expression in adipogenic vs. osteogenic differentiation
Figure 2. Number of transcripts differentially expressed in
adipogenic vs. osteogenic differentiation in ASC and BMSC. The
figure reports also the number of genes highly expressed in adipogenic
vs. osteogenic differentiation (green line) and osteogenic vs. adipogenic
differentiation (red line).
doi:10.1371/journal.pone.0032481.g002
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osteogenic vs. adipogenic differentiation.
In BMSC, the number of DEG between the two differentiations
appeared to be similar to the ASC at dd2, which was followed by a
large increase at dd7 and subsequently followed by a decrease at
dd21. In addition, adipogenic differentiation in BMSC induced
the expression of twice as many genes as compared to the
osteogenic differentiation at dd7. Surprisingly, and differently from
the ASC, the BMSC fully differentiated in bone or adipose (dd21)
had a more similar transcriptome than the two differentiating cells
at dd7 or even at dd2 (Figure 2). In BMSC there was an overall
greater number of genes with a greater expression in the
adipogenic differentiation compared to the osteogenic differenti-
ation (Figure 2).
Transcriptome dissimilarity between differentiations was greater
in BMSC compared to ASC, with a particularly greater difference
at dd7 (Figure 2). The overall data suggest that the two MSC
behave in a different way at the transcriptomics level during these
in vitro differentiations, in particular at the end of the first week.
The morphological characterization of the two differentiations
[18] demonstrated a clear adipogenic and osteogenic differentia-
tion for both MSC. Therefore, the relatively small transcriptomics
difference between adipocytes and osteocytes (at dd21) from
BMSC is surprising. In addition, from the results it is clear that for
both cell types, but in particular for the ASC, only a limited
number of DEG appeared to be necessary to drive the MSC to
differentiate to bone or adipose.
Functional enrichment analysis by IPA. Results of the
functions found to be significantly enriched by IPA with a B–H
FDR #0.05 of the DEG between adipogenic and osteogenic
differentiation in ASC and BMSC at each time point are reported
in Figure 3 and Tables S2, S3, and S4. The results of DAVID
analysis for each single time point comparison are reported in file
S6.
Several functions were significantly enriched in at least one time
point comparison (Figure 3 and Tables S2, S3, and S4). The DEG
between the two differentiations in ASC had the greatest number
of significantly enriched functions, particularly at dd2. The DEG
between differentiation in ASC did not present significant
enriched functions at dd7, and presented only 8 enriched functions
at dd21 (Figure 3). In BMSC, at dd2 and dd7 there were no
significant overrepresented functions despite the high number of
DEG compared to dd21 (Figure 2 and 3). In contrast, several
(n=14) functions were significantly enriched at dd21 for BMSC
(Figure 3 and Table S4). The lack of enriched functions with the
selected criteria (i.e., B–H FDR #0.05) in the comparison at dd7
in ASC and at dd2 and dd7 in BMSC between differentiations,
which corresponded to the larger gene size among comparisons,
was probably due to a dependence of the enrichment analysis on
the gene list size as above reported and previously pointed out
[35].
The results of IPA in DEG during each time point of
differentiations for each cell type are summarized below as follows:
At dd2 in ASC the DEG between differentiations presented a
large number of significantly enriched functions (Figure 3). In
contrast, there were not functions or pathways enriched in BMSC.
Using the ‘‘effect on function’’ analysis in IPA (Table S2) an
overall greater induction of almost all the significantly enriched
functions was uncovered for adipogenesis compared to osteogen-
esis. Tissue development and cell-to-cell signaling and interaction
were the most induced functions in adipogenesis compared to
osteogenesis (Figure 3). There was greater induction of cell
adhesion in adipogenesis compared to osteogenesis in ASC with
particular enrichment of molecules involved in adhesion of
endothelial and immune cells, and recruitment of cells (Table
S2). Other enriched functions in the comparison of adipogenesis
vs. osteogenesis in ASC were cell death, formation of connective
tissue, immune cell trafficking, cardiovascular system development
and function, tumor morphology, and hematopoiesis. The
interpretation of those functions by the ‘‘effect on function’’
analysis in IPA suggest that in ASC adipogenesis induced,
compared to osteogenesis, a higher apoptosis (with a likely larger
cell cycle as well), larger migration and cell adhesion, larger
angiogenic capacity, and greater effect on formation and
morphology of tumors (Table S2). The higher apoptosis is
supported by a significant decrease in number of cells during
adipogenesis vs. osteogenesis in ASC (Figure S2). It is also
supported by time lapse visualization of the cells during the first
24 h after initiation of differentiation (video S1, S2, S3, and S4).
The higher induced angiogenesis during adipogenic differenti-
ation compared to the osteogenic is interesting. The ASC have
been shown to be able to differentiate into endothelial cells and
participate into the formation of blood vessels in mouse model
[52,53]. Our data suggest that during the beginning of
adipogenesis there is stimulation for angiogenesis. This appears
to be in line with the evidence that vasculogenesis or angiogenesis
regulates adipogenesis (reviewed in [54]). However, for other IPA
results observed no supporting data are available because there is a
paucity of studies comparing temporal osteogenesis and adipo-
genesis in mesenchymal stem cells. Beside the functions clearly
more activated, other functions were slightly more activated
during adipogenesis compared to osteogenesis in ASC (Figure 3).
Among those it is interesting to highlight carbohydrate and lipid
metabolism. In particular the ‘‘effect on function’’ analysis
indicated a larger uptake of glucose by the cells, and a lower
phosphatidylcholine and triacylglycerol hydrolysis during adipo-
genesis compared to osteogenesis. Interestingly, the phosphatidyl-
choline is potentially involved in the control of cell growth as a
mitogenic factor [55]. The overall data indicate that ASC
undergoing adipogenesis are more prone to migrate, undergo
apoptosis, induce/participate in angiogenesis, and participate in
tumor formation than when undergoing osteogenesis. Moreover,
these cells present a larger uptake of glucose and a reduced
hydrolysis of lipids which might allowed for a larger triacylglycerol
accumulation observed as early as dd2 in few cells, but evident at
dd4 [18].
At dd21 in ASC the DEG between differentiations presented
several functions that were significantly enriched (Figure 3 and
Table S3). Lipid metabolism (particularly triacylglycerol forma-
tion) was more induced during adipogenesis compared to
osteogenesis (see also molecular transport and small molecule
biochemistry in Table S3). Cellular function and maintenance
(particularly function of the cytoskeleton) was more enriched in
DEG more induced during osteogenesis compared to adipogenesis
(Table S3). The analysis suggests that at dd21 the ASC undergoing
adipogenesis had greater cell death and lower cell cycle function
compared to those undergoing osteogenesis (Table S3). Overall the
data indicate a clear lipidogenic feature of the cells undergoing
adipogenesis compared to osteogenesis, and a more pronounced
cell morphology transformation during osteogenesis. Those
features are supported by the in vitro morphological characteriza-
tion of the same cells [18].
At dd21 in BMSC, as was the case for the ASC, the synthesis
and accumulation of lipids were among the most enriched
functions and were induced in DEG between adipogenesis and
osteogenesis (Figure 3 and details in Table S4). Cell cycle and cell
death were more pronounced in osteogenesis vs. adipogenesis with
a likely greater overall cell proliferation at dd21. This is supported
Porcine ASC and BMSC Transcriptomics
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e32481Figure 3. Functional analysis of differentially expressed genes between adipogenic and osteogenic differentiation in ASC and
BMSC. Ingenuity Pathway AnalysisH (IPA) of ASC (black bar) and BMSC (red bar) induced to differentiate towards the adipogenic and osteogenic
lineages. The blue line denotes an FDR of 0.05. The arrows present at the top of each bar denote the overall effect on the function inferred by the
Porcine ASC and BMSC Transcriptomics
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e32481by a significant greater number of cells in BMSC undergoing
osteogenesis compared to adipogenesis (Figure S2). In contrast to
the ASC, the osteogenic differentiation in BMSC had a greater
cell-to-cell signaling and interaction (particularly the activation of
cells) and antigen presentation compared to the adipogenic
differentiation. Other functions were either not more induced
during one differentiation compared to the other or were not
significantly enriched. As for ASC, the overall data clearly
confirmed the in vitro observations [18]. In addition, the data
uncovered a greater immunogenicity in BMSC undergoing
terminal osteogenesis compared to adipogenesis (Table S4).
Functional enrichment analysis by DAVID. Using
DAVID functional analysis several terms were significantly
enriched (FDR P-value #0.05) at each time point by DEG
between differentiations, with a greater number of significantly
enriched terms in ASC compared to BMSC (file S6). The analysis
uncovered as the most significant enriched functions in DEG those
related to dd2, dd7, and dd21.
At dd2 the data indicated increasing proliferation and
decreasing apoptosis and stimulation of biosynthetic processes
involving mitochondria, among DEG that were more expressed
during adipogenesis vs. osteogenesis in ASC. Binding of platelet-
derived growth factor and zinc finger protein 238, involved in
chromatin assembly (RP58), and the neuron-specific transcription
factor OLF1 as TFBS, were significantly enriched in DEG with
greater expression during osteogenesis vs. adipogenesis in BMSC.
At dd7 protein synthesis and acetylation were the most enriched
functions among DEG that were more expressed during
adipogenesis vs. osteogenesis in both ASC and BMSC, and
GTPase activity in DEG that were more expressed during
osteogenesis vs. adipogenesis in ASC and BMSC. At dd21 fatty
acid metabolic processes involving NADP and PPAR signaling
were among the most enriched functions in DEG more expressed
during adipogenesis vs. osteogenesis in ASC. Methylation,
cytoskeleton organization and cell division were the most enriched
functions in DEG more expressed in osteogenesis vs. adipogenesis
in ASC. In BMSC, the data indicated a significant enrichment of
functions related to lipid biosynthesis, particularly sterol biosyn-
thesis, and PPAR signaling in DEG that were more expressed in
adipogenesis vs. osteogenesis.
Overall pathway enrichment. Among more than 200
pathways present in IPA there were 15 that were significantly
(FDR P-value #0.05) enriched in at least one time point among
the DEG between the adipogenic and osteogenic differentiation in
ASC and BMSC (Figure S3). None of the pathways were
significantly overrepresented in DEG between differentiations at
dd2. Five and 12 pathways were significantly enriched in DEG
between differentiations in ASC at dd7 and dd21, respectively (see
file S7). Three of those pathways were enriched in DEG between
differentiations in both dd7 and dd21: CCR5 signaling in
macrophages, cardiac hypertrophy signaling, and a-adrenergic
signaling (Figure S3). Those three pathways have in common the
signaling from G-proteins and calmodulin groups, both more
expressed in osteogenic vs. adipogenic differentiation (file S7). The
CCR5 pathway is involved in chemotaxis, the cardiac hypertrophy
pathway is involved in cell proliferation, and the a-adrenergic
pathway plays an important role in the regulation of adipose tissue
lipolysis [56], among others. IL8 and relaxin signaling were
significantly enriched only in DEG between differentiations in
ASC at dd7. As for the above pathways, also for IL8 and relaxin,
an important role is played by G-proteins (file S7). The G-proteins
group appears to be an important hub in the ASC decision to
move toward adipogenesis or osteogenesis. The small G-proteins
are a superfamily of proteins with a myriad of roles; with minor
variations in GTP/GDP-binding core domain they have a role in
nearly every known signaling process in cells including vesicular
targeting, nuclear transport, and growth factor signaling for
maintenance of the spatial cycles [57]. Our data appear to be
supported by previous results, where the down-regulation of a
gamma 5 G-protein was essential for the onset of adipogenic
differentiation [58].
The other pathways enriched significantly in DEG between the
two differentiations in ASC at dd21 (Figure S3) included pathways
involved in cellular movement, cytoskeleton signaling, and fatty
acid biosynthesis. The first two categories of pathways were more
induced in osteogenesis compared to adipogenesis (see depiction of
the pathways in file S7). As for the pathways discussed above, those
pathways have in common the signaling involving CCR receptors
and G-proteins. In particular, the CCR3 signaling was the most
significantly enriched pathway (Figure S3, file S7). The activation
of CCR3 receptor by chemokines, besides stimulating intracellular
calcium release and production of active oxygen species, produces
changes in actin polymerization allowing the chemotaxis of
eosinophils. Human CD34
+ cord blood progenitor cells and
CD34
+ progenitors from bone marrow express the CCR3 receptor
[59,60]. Moreover, CCR3-dependent chemokine interactions
control migration of CD34
+ progenitors from bone marrow to
sites of injury such as ischemic myocardium [60]. In our case, the
pathway appeared to be more induced during osteogenesis
compared to adipogenesis.
The detail visualization of the chemokine signaling pathway (file
S7) allowed uncovering a greater expression of CXCR4 gene
during adipogenesis compared to osteogenesis in ASC. This gene
codes for a receptor that specifically binds SDF-1 [61]. The
interaction of another chemokine receptor, the CXCR4, with
SDF-1 is known to be important in hematopoietic stem cell
homing and quiescence [62,63]. Moreover, it has been shown that
in vitro over-expression of CXCR4 induces human ASC migration
in response to SDF-1 [64]. In another in vitro study of ASC, the
interaction of CXCR4, expressed by ASC, with its ligand SDF-1
induced ASC chemotaxis [65]. The SDF-1 is secreted by adipose-
derived capillary endothelial cells. Our data suggest that ASC
undergoing adipogenic differentiation may be less sensitive to
chemokines that bind CCR3 but more sensitive to those that bind
CXCR4 compared to ASC cells undergoing osteogenic differen-
tiation.
Other pathways related to cell motility/cytoskeleton signaling in
adipogenic vs. osteogenic differentiation in ASC at dd21 induced
‘ephrin receptor signaling’ and ‘fMLP signaling in neutrophils’
(Figure S3, file S7). Ephrin receptor signaling can affect cell
migration by modifying cytoskeletal organization and cell adhesion
[66]. It also seems that this receptor signaling can influence
numerous biological processes such as cell proliferation and fate
[66], cell-cell interaction, morphology and angiogenesis [67]. The
fMLP signaling has been related to the chemotaxis of phagocytic
leukocytes towards inflammatory sites [68].
gene annotation using IPA (NN=highly activated in adipogenic vs. osteogenic differentiation; N=activated in adipogenic vs. osteogenic
differentiation; q=tends to be activated in adipogenic vs. osteogenic differentiation; OO=highly activated in osteogenic vs. adipogenic
differentiation; O=activated in osteogenic vs. adipogenic differentiation; Q=tends to be activated in osteogenic vs. adipogenic differentiation;
«=not apparent overall activation or inhibition).
doi:10.1371/journal.pone.0032481.g003
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and cytoskeleton modification during osteogenesis compared to
adipogenesis in ASC. This is consistent with our in vitro
observations [18] where ASC undergoing osteogenic differentia-
tion moved to form large cell clusters to produce columnar-shaped
nodules. This behavior was not observed during adipogenesis nor
was observed in BMSC during either differentiation. For BMSC,
only one pathway (LPS/IL1 mediated inhibition of RXR function)
was found to be significantly enriched by the DEG between
differentiations at dd21 by IPA (file S7). The same pathway was
enriched for the ASC, as well (Figure S3). In both cases the
pathway was more induced during adipogenesis compared to
osteogenesis mostly as a result of a greater expression of genes
coding for proteins involved in lipid metabolism.
In DAVID few Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathways were significantly enriched (FDR P-value
#0.05) (Table 2). Among those, ribosome (dd7) and PPAR
signaling (dd7 and dd21) were enriched in DEG that were over-
expressed in adipogenic vs. osteogenic differentiation in both
MSC. At dd2 the DEG more expressed in adipogenic vs.
osteogenic differentiation in ASC significantly enriched pathways
involved in inflammation and cancer (Table 2). At dd21 the DEG
more expressed in BMSC undergoing adipogenesis vs. osteogenesis
enriched significantly steroid biosynthesis, as well as PPAR
signaling. Those data indicate that PPAR signaling is the most
important pathway in differentiating cells toward adipocytes. This
finding is not novel but confirms the fact that PPAR activation, in
particular PPARc, is essential for adipogenesis [69]. Moreover,
this analysis clearly identifies PPAR signaling as one of the most
important pathways that distinguish differentiation of cells toward
adipogenesis vs. toward osteogenesis. This conclusion is supported
by previous data showing that mouse homozygous PPARc-
deficient ES cells failed to differentiate into adipocytes, but
spontaneously differentiated into osteoblasts [70]. Besides PPAR
signaling, our data highlighted a crucial role of the protein
synthesis machinery (i.e., ribosome) in driving MSC to differen-
tiate into adipocytes instead of osteocytes (Table 2). In both MSC
the enrichment of DEG associated with ribosomes (i.e., protein
synthesis) happened within one week of the in vitro differentiation
process. It is interesting that the quantity of RNA/cell (Figure S4)
had a significant increase during the first week of differentiation,
particularly during osteogenesis.
The DAVID analysis confirmed the significant enrichment of
pathways involved in inflammation and cancer among DEG more
expressed in adipogenesis vs. osteogenesis in ASC at dd2 first
uncovered by the functional analysis in IPA (i.e., immune cell
trafficking and tumor morphology, described above). The
pathways indicated that the ASC during adipogenesis may have
a greater anti-inflammatory behavior [higher expression of the
inhibitor of NFkB( IKBKG)], and a greater secretion of multiple
cytokine-like molecules with chemotactic and angiogenic effect
(CCL2, CCL5, and VEGFA) compared to the osteogenic differen-
tiation. Many of the same genes are also involve in pathways
related to cancer. The results appear to indicate a greater
tumorigenesis capacity for ASC during early adipogenesis
compared to osteogenesis. However, tumor formation is not
strictly a cellular phenomenon and the suggestion by those data
needs to be taken with caution. The DEG involved in angiogenic
capacity are all factors (i.e., CCL2, CCL5, and VEGFA) released by
cells and known to affect positively the formation of vessels; thus,
this last can be considered more likely as a direct cellular effect.
From IPA, fatty acid biosynthesis was significantly enriched in
adipogenesis vs. osteogenesis only in ASC (Figure S3, file S7),
consistent with a greater utilization of fatty acids for triacylglycerol
formation in ASC. Interestingly, the IPA did not uncover the same
enrichment in DEG between differentiations in BMSC; however,
DAVID uncovered in both MSC the central role of PPAR
signaling in guiding the MSC toward the adipogenic differentia-
tion. In addition, the functional analysis using DAVID uncovered
an important role of steroid biosynthesis for the formation of
cholesterol among DEG more expressed in adipogenic vs.
osteogenic differentiation in BMSC. The same functions were
not revealed to be significantly enriched in IPA, probably due to
different knowledge base compared to DAVID. However, this
finding highlights the limitation on relying on a single bioinfor-
matics tool in performing functional analysis of microarray data
[35]. In summary, the data highlight the central role of PPAR
signaling and differences between the two MSC. Moreover, IPA
results might explain the greater overall lipid accumulation in ASC
vs. BMSC previously observed [18].
Transcriptome comparison between ASC and BMSC
during adipogenic and osteogenic differentiation
Correlation analysis. In line with the above reported overall
coefficient of correlation for the complete transcriptome between
BMSC and ASC, the same analysis for each time point showed a
significant (P-value,0.0001) and positive Pearson correlation
between BMSC and ASC (0.79, 0.72, and 0.85, for dd2, dd7,
and dd21, respectively). The overall correlation was higher for the
osteogenic (r=0.79) compared to the adipogenic (r=0.76)
differentiation (Table S1). The lower correlation seen for the
Table 2. KEGG pathways significantly enriched with a
Benjamini-Hochberg FDR #0.10 in DAVID analysis for DEG
between adipogenesis and osteogenesis in ASC and BMSC.
Pathway # genes p-value Benjamini
DEG more expressed in adipogenic vs. osteogenic differentiation
ASC
dd2
hsa04621:NOD-like receptor signaling
pathway
4 0.002 0.059
hsa04060:Cytokine-cytokine receptor
interaction
6 0.001 0.069
hsa05200:Pathways in cancer 7 0.004 0.080
dd7
hsa03010:Ribosome 10 ,0.001 ,0.001
hsa03320:PPAR signaling pathway 5 0.004 0.100
dd21
hsa03320:PPAR signaling pathway 7 ,0.001 0.012
BMSC
dd7
hsa03010:Ribosome 13 ,0.001 ,0.001
dd21
hsa00100:Steroid biosynthesis 4 ,0.001 0.003
hsa03320:PPAR signaling pathway 5 0.003 0.006
DEG more expressed in osteogenic vs. adipogenic differentiation
BMSC
dd7
hsa04810:Regulation of actin
cytoskeleton
11 0.001 0.088
doi:10.1371/journal.pone.0032481.t002
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presented an overall correlation between the two cell types of
r=0.61 (Table S5). The same animal also had the lowest
correlation during the osteogenic differentiation (Table S6). The
overall correlation between pigs was lower for the BMSC
compared to the ASC. The correlation considering only overall
DEG (FDR #0.05) was 0.76. Overall those data highlight a large
similarity in gene expression between the two MSC undergoing
the osteogenic and adipogenic differentiation with some variation
between animals, and with a more consistent transcriptome
between animals in ASC compared to BMSC.
Number of DEG. The number of DEG between BMSC and
ASC at the beginning (dd2) of the in vitro differentiation was 191
and 106 for the adipogenic and osteogenic differentiations,
respectively (Figure 4), but already at dd7 the number dropped
to 30. During the osteogenic differentiation the number of DEG
between BMSC and ASC continued to decrease over time with
only 28 DEG between the two cell types at dd21 as it was for dd21
adipogenic differentiation (23 DEG). The data also showed that
during the adipogenic differentiation ASC had more genes with a
greater expression compared to BMSC until dd7 (Figure 4). For
the osteogenic differentiation more genes with a higher expression
in ASC vs. BMSC were present at dd2; afterwards, the genes with
a higher expression in BMSC vs. ASC were relatively more
numerous. These results, together with data at dd0 reported
above, strongly support a relatively larger difference between the
two MSC during the early phases of differentiation compared to
late differentiation.
Overall functional enrichment analysis. Significant
enrichment of IPA functions (FDR P-value #0.05) by DEG
between BMSC and ASC in adipogenic and osteogenic
differentiation in at least one time point are reported in Figure 5.
Different from the comparison between differentiations, IPA
identified several enriched functions among the DEG between the
two MSC. In contrast, the analysis with DAVID resulted in few
terms significantly enriched (FDR P-value #0.05; file S8). To
facilitate the interpretation of the enrichment analysis the
functions are discussed in 6 clusters, as related to: immune
function, metabolism, system development and function, cell cycle,
signaling, and morphology.
For the immune function data indicated that all significantly
enriched immune-related functions by DEG between BMSC and
ASC in the adipogenic differentiation had a greater induction in
ASC vs. BMSC (Figure 5 and Tables S7, S8, and S9), especially at
dd2. Functions related to movement of immune-related cells were
among the most important functions, with an indication of a
greater induction in ASC vs. BMSC mediated through a potential
greater release of chemotactic factors (e.g., CXCL2 and IL1A).
However, several other functions related to adhesion of immune-
cells and inflammation also were more expressed in ASC vs.
BMSC (e.g., NFKB1A and VCAM1). Interestingly, a larger
induction of immune-related functions was observed in BMSC
vs. ASC during the osteogenic differentiation (Figure 5 and Table
S10, S11). Overall, the data suggest a slightly greater inflammatory
response in the differentiation proper of each MSC (e.g., in
adipogenesis for ASC and osteogenesis for BMSC). The biological
meaning of this effect is not apparent. Moreover aside from dd2,
where the number of DEG was relatively numerous, at the other
dd the number of DEG in each function was relatively low (,3–4
genes) and the potential biological meaning may be insignificant.
Among the metabolic functions lipid metabolism was the most
enriched. The effect on function analysis of DEG between BMSC
and ASC during the adipogenic differentiation suggested a greater
lipid metabolism (especially accumulation of lipids) in ASC vs.
BMSC during the first week of adipogenic differentiation (Figure 5
and S7, S8, S9). Those data are in accordance with the greater
lipid droplet formation observed in ASC vs. BMSC [18]. The
analysis of DEG between BMSC and ASC during the osteogenic
differentiation also suggested a greater lipid metabolism in ASC vs.
BMSC at dd2 (Figure 5 and Table S10). These data appear to
suggest that the ASC also tend to retain a greater lipid metabolism
function compared to BMSC during the osteogenic differentiation.
The analysis with DAVID of DEG more expressed during
osteogenesis in BMSC vs. ASC at dd2 only uncovered enrichment
among metabolic-related functions associated with steroid biosyn-
thesis (file S8, Sheet 4).
Among the functions of the System Development and Function
(SD&F) group, in addition to the hematological SD&F included in
the above discussion of the immune-related functions, cardiovas-
cular and connective SD&F were significantly enriched in almost
all the comparisons (Figure 5). The effect on function analysis
indicated a greater induction at dd2 for both adipogenesis and
angiogenesis in ASC vs. BMSC during in vitro adipogenesis (Table
S7). The greater adipogenesis response in ASC vs. BMSC is in line
with previously observed morphological measurements [18]. A
greater angiogenic response in ASC vs. BMSC was also suggested
by the data at dd21 during osteogenic differentiation (Table S11).
The ASC express the CD34 surface marker [19]. A positive
Figure 4. Number of transcripts differentially expressed in
BMSC vs. ASC during adipogenic and osteogenic differentia-
tion. Number of transcripts differentially expressed in BMSC vs. ASC in
adipogenic and osteogenic differentiation at each time point. The
image reports also the number of genes more expressed in BMSC vs.
ASC (red line) or more expressed in ASC vs. BMSC (green line).
doi:10.1371/journal.pone.0032481.g004
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reported in the rat [71]. The BMSC also actively enhance
angiogenesis in vivo [72], but the ASC have a greater angiogenic
capacity. Moreover, it appears that angiogenesis needs to precede
adipogenesis in the normal adipose tissue development [33]. Other
functions related to development (tissue, cell, and embryonic
development) were significantly enriched, especially in early
adipogenic differentiation. The effect on function analysis
Figure 5. Functional analysis of differentially expressed genes between BMSC and ASC during adipogenic and osteogenic
differentiation. Ingenuity Pathway AnalysisH (IPA) of BMSC vs. ASC induced to differentiate towards the adipogenic (black bar) and osteogenic (red
bar) lineages. The blue line denotes an FDR of 0.05. The arrows denote the overall effect on the function inferred by the gene annotation using IPA
(NN=highly activated in BMSC vs. ASC; N=activated in BMSC vs. ASC; q=tends to be activated in BMSC vs. ASC; OO=highly activated in ASC vs.
BMSC; O=activated in ASC vs. BMSC; Q=tends to be activated in ASC vs. BMSC; «=not apparent overall activation or inhibition). Functions with
‘‘effect on functions’’ with only 1 gene were not considered for the analysis (i.e., not arrows; see Tables S7, S8, S9, S10 and S11 for details).
doi:10.1371/journal.pone.0032481.g005
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compared to BMSC (Table S7, S8 and S9). Moreover, it also
uncovered a greater differentiation of the BMSC compared to
ASC towards bone tissue during early osteogenesis (Table S10).
Among the cell cycle functions four were the most enriched: cell
cycle, cell death, cellular growth and proliferation, and DNA
replication, recombination, and repair (Figure 5). The interpreta-
tion of the data using the effect on function in IPA (Table S7, S8,
S9, S10, and S11) indicated that at dd2 cell death was higher in
BMSC during adipogenesis and lower in BMSC during osteogen-
esis vs. ASC. The same data suggested a greater cellular growth in
BMSC compared to ASC in both osteogenesis and adipogenesis
through the whole differentiation. The data also indicated a
greater cell cycle function at the beginning of osteogenesis in
BMSC vs. ASC (Figure 5 and Table S10). The overall data appear
to indicate a greater cell proliferation in BMSC at the early phases
of both differentiations compared to ASC. These data are partly
supported by the data on the number of cells (Figure S2). In fact,
the cell number increased significantly through dd21 in BMSC
undergoing osteogenesis but not undergoing adipogenesis; while
within the same time frame ASC undergoing adipogenesis had a
significant decrease in cell number. Overall the number of cells
was significantly greater in BMSC compared to ASC during both
differentiations (Figure S2). Our in vitro data using a 3D system also
support a larger cell proliferation in BMSC compared to ASC
during late osteogenesis [17].
For the signaling four functions were identified by IPA and were
related to: cell signaling, cell-to-cell signaling and interaction,
cellular compromise, and cellular movement (Figure 5). The
interpretation of IPA results indicated that during early adipo-
genesis the BMSC had a greater movement but a lower migration
(i.e., immune cell trafficking from IPA) compared to ASC, while
the ASC had a greater ability to adhere to other cells and were
more activated (i.e., more sensitive to external signals as suggested
by cell-to-cell signaling from IPA) (Table S7). This latter feature in
ASC vs. BMSC appeared to be retained at dd7 with greater
hydrolysis of GTP and calcium release. At this same time, data
also indicated that ASC appeared to have more synthesis of nitric
oxide compared to BMSC (Table S8). Nitric oxide is an important
factor in increasing blood flux and angiogenesis [73]. Release of
nitric oxide appears to be part of the immunomodulatory
mechanism in MSC [74]. During the osteogenic differentiation,
data indicated a greater induction of cell movement and
immunomodulatory effects (i.e., deletion of T-lymphocytes) in
ASC vs. BMSC (Tables S10, S11). Overall, our data appear to
indicate, as reported above, a greater angiogenic effect and a more
pronounced immunomodulatory effect of ASC vs. BMSC during
both differentiations, but with a relatively greater effect during the
adipogenic differentiation. DAVID analysis uncovered a signifi-
cant enrichment of signal and secretion in DEG more expressed in
BMSC vs. ASC at dd7 of osteogenesis (file S8, Sheet 5). Moreover,
the angiogenesis and cell adhesion was significantly enriched in
DEG more expressed in ASC vs. BMSC at dd2 of adipogenesis,
confirming the conclusion from IPA analysis (file S8, Sheet 1).
The function morphology included a cluster of five functions:
cell morphology, cellular assembly and organization, cellular
function and maintenance, tissue morphology, and tumor
morphology (Figure 5). The interpretation of IPA functions
indicated that there was not a greater morphogenesis in one cell
type vs. the other during adipogenesis (Tables S7, S8, and S9).
Interestingly, the data suggested a greater tumorigeneicity for ASC
vs. BMSC at dd2 of adipogenesis. During osteogenesis several of
the functions related with morphology were significantly enriched,
but there were no specific differences uncovered between the two
MSC. However, the IPA revealed a greater tissue morphology
function for BMSC vs. ASC in early osteogenesis (dd2). The DEG
between BMSC and ASC in early osteogenesis were overrepre-
sented by genes related to bone loss and increased thickness of
connective tissue (Table S10). A direct comparison between ASC
and BMSC for tumor proliferation has not been performed, but
recent data indicate a specific homing and contribution for tumor
growth and proliferation by transplanted MSC [75]. The
relationship of the tumor growth function to the MSC is not
clear, but it may have contrasting effects: on the one hand MSC
inhibit tumor formation by releasing anti-tumor factors, while on
the other hand MSC actively increase angiogenesis in tumor
masses [76]. In addition, it has been shown that human ASC
promote tumor growth in mouse [77]. Our data indicate a
potentially greater tumorigenesis effect in ASC during adipogen-
esis compared to BMSC. Those conclusions however need to be
verified by in vivo experiments. The analysis with DAVID
uncovered a significant enrichment of adherens junction and
extracellular region, including collagen-related terms, in DEG that
were more expressed in ASC vs. BMSC at dd2 of adipogenesis,
(file S8, Sheet 1). Other results from DAVID confirmed IPA
results.
Overall pathway enrichment. Only 4 pathways were found
to be significantly enriched by IPA (FDR P-value #0.05) in at least
one time point comparison among the DEG between BMSC and
ASC during adipogenic and/or osteogenic differentiation (Figure
S5, details in file S7). In DAVID only the ‘ECM-receptor
interaction’ was significantly enriched in DEG more expressed in
ASC vs. BMSC at dd2 of adipogenesis (file S8, Sheet 1). In IPA
only the ‘14-3-3 mediated signaling’ was enriched at dd2 of
osteogenic differentiation while ‘keratan sulfate biosynthesis’,
‘LPS/IL-1 mediated inhibition of RXR function’, and ‘sulfur
metabolism’ were enriched at dd21 of adipogenic differentiation.
Among those only the ‘keratan sulfate biosynthesis’ was obviously
more enhanced in ASC vs. BMSC during adipogenesis. The
significance of this is not readily apparent; however, the higher
amount of keratin sulfate might indicate a lower adherence or a
lower migration [78] of ASC during adipogenesis compared to
osteogenesis.
Network between DEG
In order to uncover potential interactions between DEG in each
comparison we have run network analysis using IPA, considering
all the potential interactions between genes. Results are reported
in file S7. Few observations from such analysis can be made: the
larger network in osteogenic vs. adipogenic differentiation was
observed at dd7 for BMSC and at dd21 for ASC. Interestingly, in
both comparisons the networks were almost completely formed by
genes more expressed in osteogenic vs. adipogenic, suggesting that
the differentiation toward osteogenesis requires a large interaction
of genes products compared to adipogenesis.
Networks formed by DEG between differentiations in ASC
showed an apparent central role for CEBPA in controlling
expression of genes more expressed in adipogenic vs. osteogenic
and YWHAZ (Tyrosine 3-monooxygenase/tryptophan 5-mono-
oxygenase activation protein, zeta) in regulating expression of
genes more expressed in osteogenic vs. adipogenic. For BMSC the
largest network was observed at dd7 with ESR1 (estrogen receptor
1) and a network encompassing YWHAZ, RARA (retinoic acid
receptor), NKX2-1 (NK2 homeobox 1 or Thyroid transcription
factor 1), CDC42 [cell division cycle 42 (GTP binding protein,
25 kDa)], and ATXN1 (ataxin 1) playing a central role in
controlling expression of genes more expressed in osteogenic vs.
adipogenic. Interestingly, a central role of IL1B was revealed by
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MSC, but in particular in BMSC (file S7).
The proteins coded by DEG between MSC in each differen-
tiation produced small interactive networks with few genes likely
playing a central role (file S7).
Adipogenic and osteogenic markers
The detailed presentation of the results and discussion for
finding specific adipogenic and osteogenic markers is reported in
file S1 and S10. The results indicate that NAD(P)H dehydrogenase
quinone 1 (NQO1) is the best overall marker of adipogenesis
followed by aquaporin 3 (AQP3), stearoyl-CoA desaturase (SCD),
fatty acid binding protein 3 and 5 (FABP3 and FABP5), and ferritin
light polypeptide (FTL). For osteogenesis the best markers were
hemopexin (HPX), collagenase type 3 a1( COL3A1), annexin A8-
like 1 (ANXA8L1), flotillin 2 (FLOT2), and periostin or osteoblast
specific factor (POSTN).
Limitations
The experiment and methods used have several limitations that
need to be acknowledged. It is generally accepted that the in vitro
experimental conditions are different from the in vivo conditions.
For stem cells this is particularly true as they are maintained in an
undifferentiated state by the in vivo ‘‘niche’’ [79]. In the in vitro
environment most of the niche environmental conditions are
absent. Therefore, the data generated and conclusions need to be
verified in an in vivo milieu. In addition, the in vitro conditions used
in the present experiment are effective in inducing osteogenic and
adipogenic differentiation [18] however we do not know if those
conditions are optimal for those differentiation processes. In
support of this, recent data showed that use of different media
critically changed the performance of rabbit MSC [80].
The microarray platform used contained ca. 10,000 genes,
which is probably less than half of the complete mRNA pool in
pig. Thus, all conclusions are inferred using less than half of the
complete genome information. In addition, using DAVID the
enrichment analysis revealed that the platform is significantly
enriched by several terms compared to the whole genome (file
S11), indicating that the genes coded by the oligos in the platform
are not completely randomly distributed in the whole genome.
The enrichment analysis presents several limitations [35,81] for
a full biological interpretation of the data. Among those, the most
critical is the substantial effect of the dimension of the gene list in
determining the final enrichment. A consequence of this limitation
is the difficulty and inaccuracy in comparing functional analysis
between gene lists [35]. Both IPA and DAVID do not provide any
buffer/adjustment to address such limitation. Despite those
limitations the enrichment analysis is still the most accepted
method to uncover the most important ‘‘biological effect’’
contained in the lists of DEG.
Our porcine microarray was annotated using human Entrez
gene ID; therefore, DAVID results for the UCSC-TFBS have to
be taken with caution since the human promoter region can have
different motifs compared to the porcine promoter region.
Concluding remarks
The data generated by the present study suggest:
The undifferentiated ASC and BMSC have a low expression of
genes related to the immune system and hematopoiesis; thus
suggesting, as for human, that porcine ASC and BMSC are
immune-privileged;
There is a large variation of the ASC and BMSC transcriptome
between animals but there are relatively few genes differentially
expressed between the two cell types. The functional analysis of
DEG between these porcine MSC indicated a greater myogenic
capacity of the ASC vs. BMSC but also a greater angiogenesis,
migration capacity, bone formation capacity, and neuronal
differentiation capacity. In addition there was a greater likelihood
of the undifferentiated BMSC for differentiating toward liver and
pancreas compared to the undifferentiated ASC. Moreover, those
differences appeared to be under the control of few TF, such as
BRACH, HSF2, SRY, RFX1, and ARP1;
The direct comparison between differentiations uncovered
relatively few genes as crucial in determining the osteogenic or
adipogenic fate of MSC, with a larger transcriptomics difference
between differentiations of BMSC compared to ASC at the end of
the first week of differentiation. Functional analysis allowed
identifying cytoskeleton modification and lipid metabolism as the
most crucial functions. The functional analysis uncovered a crucial
role for the G-proteins and PPAR signaling in directing the cell to
differentiate into osteocytes or adipocytes. In addition, the data
indicated that MSC undergoing adipogenic differentiation are
more angiogenic and, may be more prone to induce tumor
formation. This latter observation was more pronounced in ASC
compared to BMSC;
The transcriptome of ASC and BMSC during the two
differentiations was similar. The transcriptome between the two
MSC became virtually equal after the first week of differentiation.
The functional analysis of the few DEG indicated that ASC
retained in any condition a greater capacity for lipid metabolism
and migration than BMSC. Moreover, the ASC were more
angiogenic, and probably more tumorigenic, and had less
proliferative capacity compared to BMSC under same conditions.
Our data also suggested that MSC undergoing differentiation of
the tissue of origin (ASC in adipose and BMSC in bone) were
more prone to induce inflammation than when undergoing
differentiation to the other tissue.
Finally, we have identified several adipogenic and osteogenic
markers, some of which have not been reported previously. The
NQO1 appeared to be the best adipogenic marker followed by
AQP3 and SCD. Good osteogenic markers appeared to be HPX,
COL3A1, and ANXA8L1;
The conclusions from the present investigation allow proposing
a model (Figure 6). This model provides several hypotheses that
need to be verified by in vitro and/or in vivo studies with direct
comparisons between the two MSC.
Prospective
Even though our study confirmed a similar transcriptome (i.e.,
few DEG in direct comparisons) between BMSC and ASC both at
the undifferentiated status and during osteogenic and adipogenic
differentiation, the few DEG can have a great impact for the
potential therapeutic application of these cells. To understand the
potential impact of those few DEG and, overall, to uncover the
best stem cell treatment for each specific ailment, the two MSC
need to be tested by direct comparison of their bone healing
capacity in in vivo experiments. We believe that this should be one
of the priorities for the research in clinical application of stem cells
in the future.
Materials and Methods
Ethics Statement
Subcutaneous back fat and bone marrow from femurs were
harvested from three castrated Yorkshire crossbred male pigs
under a protocol approved for this study by the University of
Illinois Institutional Animal Care and Use Committee (IACUC
#04296).
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adipogenic differentiation
ASC and BMSC were isolated, cultured, and induced to
differentiate in adipogenic and osteogenic lineages as described
previously [18].
Microarray and qPCR analysis
In a previous study [18] we characterized and directly
compared by histological staining and qPCR analysis the in vitro
differentiation of ASC and BMSC towards the osteogenic and
adipogenic lineages. Based on the results obtained we chose the
time points for the microarray analysis of this study. At 0, 2, 7, and
21 days of differentiation (dd) cells were trypsinized and total RNA
was immediately isolated using the RNeasyH Mini Kit (Qiagen
Sciences, Germantown, MD) according to the manufacturer’s
protocol. Any residual genomic DNA was eliminated using
RNase-Free DNase SetH (Qiagen). RNA concentration was
measured with a NanoDrop ND-1000 spectrophotometer (Nano-
Drop Technologies, Wilmington, DE, http://www.nanodrop.
com). The purity of RNA (A260/A280) was .1.90.
Total RNA (10 mg) from samples and a reference standard
derived from a mixture of porcine tissues (RNA from jejunum,
liver, kidney, and mammary tissue in 34%, 32.5%, 32.5%, and
Figure 6. Functional model summarizing the main findings from the present study. Results from the transcriptome analysis of ASC and
BMSC induced to differentiate towards the adipogenic and osteogenic lineages suggest: prior differentiation the ASC appear to be more myogenic
compared to the BMSC, while these latter appear to be more prone to migrate, to induce angiogenesis, and to differentiate into bone and neurons
compared to the ASC. Both MSC have a low expression of several genes related to immune response and hematopoiesis, while they express in large
amount genes involved in formation of collagen, immune suppression, and angiogenesis. All those data strongly support an immunomodulatory and
angiogenic capacity of MSC with few (but maybe crucial?) differences between BMSC and ASC. During early osteogenic differentiation the data
suggest ASC having larger lipid metabolism, migration, and immunomodulatory capacity compared to BMSC, while BMSC have larger induction of
inflammation, cell growth, and cell proliferation with a likely larger production of cholesterol. In late osteogenesis ASC appear to have larger
angiogenic capacity compared to BMSC. During early adipogenesis the ASC appear to be more prone to induce inflammation, to have higher cell
adhesion, tumorigenesis, and angiogenesis compared to BMSC, while BMSC have larger cell proliferation and growth, migration, and cytoskeleton
modification compared to ASC. The cell growth appears to be more induced in BMSC vs. ASC also at the end of adipogenesis. The direct comparison
between differentiations suggest an early larger cell proliferation and later larger cell migration (only in ASC) and cytoskeleton modification in
osteogenesis vs. adipogenesis with a crucial role of G-proteins. A larger migration and angiogenesis in early differentiation and larger lipid
metabolism and tumorigenesis in later differentiation seem to characterize the adipogenic vs. osteogenic differentiation with a pivotal role of PPAR
signaling.
doi:10.1371/journal.pone.0032481.g006
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labeled cDNA followed by incorporation of Cy3-ester and Cy5-
ester (Amersham, Piscataway, NJ) as previously described [82]
with slight modifications (see file S1). Each experimental sample
was co-hybridized with an equal amount of labeled cDNA of the
reference standard.
A 13,309 oligo 70-mers array developed by Operon (Sus scrofa
AROS V1.0 with extension) [83] spotted in duplicate on amino
silane-coated glass slides was used for transcript profiling. The
platform contained oligos for ca. 10,000 unique annotated genes.
Annotation was based on similarity searches (September 2007)
using sequential Basic Local Alignment Search Tool (BLASTN
and TBLASTX against human and mouse UniGene databases
and the human genome) as previously described [84]. Details of
the microarray are reported in file S1. Slides were scanned for
both dye channels with a Scanarray 4000 (GSI-Lumonics,
Billerica, MA) dual-laser confocal scanner and images were
processed and edited using GenePix 6.0 (Axon Instruments,
Concord, ON, http://www.moleculardevices.com). Array quality
was assessed using homemade software written in Perl language as
previously described [82]. Details of the microarray protocol are
reported in file S1. In order to validate the microarray analysis
accuracy a direct comparison with data from quantitative RT-
PCR (qPCR) for 14 genes previously published using the same
samples [18] was performed (file S2).
Microarray data are deposited in the National Center for
Biotechnology Information (NCBI) Gene Expression Omnibus
(GEO) database (accession GSE25854).
Statistical Analysis
Microarray spots with median intensity $3 standard deviation
above the median of the background and GenePix flag .100 were
applied as filters to ensure high quality data. Data from a total of
82 microarrays were adjusted for dye and array effect (Loess
normalization and array centering), duplicated spot intensities
were not averaged and were subsequently used for statistical
analysis. A mixed model with repeated measures was then fitted to
the normalized log2-transformed adjusted ratios (sample/refer-
ence standard) using Proc MIXED (SAS, SAS Inst. Inc., Cary,
NC). The model included the fixed effects of time (2, 7, and
21 dd), cell type (ASC and BMSC), differentiation (osteogenic and
adipogenic), interactions: time6cell type6differentiation; time6
differentiation; time6cell type; cell type6differentiation. Dye and
expression at dd0 was a covariate and pig (n=3) was considered as
random effect. P-values were adjusted for the number of genes
tested using Benjamini and Hochberg’s false discovery rate (FDR)
[85] to account for multiple comparisons. Differences in relative
expression were considered significant at an FDR-adjusted
P#0.05 for time6cell type6differentiation. Post-hoc P,0.001
was considered significant between pairwise comparisons. For the
comparison between the two cell types before differentiation (dd0)
a second statistical analysis was run excluding dd0 as covariate and
using a FDR #0.05 cut-off for the overall MSC effect (i.e.,
considering all time points) and with P,0.001 between the two
MSC at dd0. The difference in expression of genes is reported as
fold change (2-fold=100% change). All correlation analyses were
performed using Proc Corr of SAS (SAS Institute, Cary, NC). The
contrasts between factor levels and P-values are reported in file S2.
Data mining
The data mining analysis of the transcriptome was performed in
three separate result sub-sets: 1) at dd0 or prior to differentiation,
which included differentially expressed genes (DEG) between the
two MSC, genes highly expressed in MSC, and genes more
expressed in MSC compared to fully differentiated tissues (i.e.,
microarray reference RNA, see above); 2) on DEG between
differentiations in each MSC for each time point; and 3) on DEG
between MSC within each differentiation for each time point.
The functional analysis was performed using Ingenuity Pathway
Analysis (IPA; IngenuityH Systems, Mountain View, CA) and
Database for Annotation Visualization and Integrated Discovery
(DAVID) [86]. The use of multiple tools is highly recommended
for functional analysis of microarray data [35].
For the IPA the entire microarray data set with associated
statistical FDR P-values were considered using GenBank or
HUGO ids. The annotated oligos in the pig array were used as the
reference set for functional and canonical pathway analysis. In
IPA, functions and pathways were considered significantly
enriched with a threshold of FDR P-value #0.05. The
interpretation of IPA data is as reported previously [87] and
described in file S1.
The same gene lists as for IPA and the gene list of up- and
down-regulated DEG were analyzed in DAVID [86] using Entrez
Gene ID, and the entire annotated pig array was used as
background. Analysis was run using default functional categories
tools of DAVID plus UP-Tissue and UCSC-TFBS (transcription
factor binding site). Results that had an EASE score #0.1 were
considered and all reported following suggestions from Huang da
et al. [86]. Results with an EASE score #0.1 were discussed only
when not terms were enriched with a Benjamini-Hochberg (B–H)
multiple comparison #0.05, otherwise a B–H #0.05 was used as
cut-off. For some analysis the Functional Annotation Clustering
tool in DAVID [86] was used with the highest classification
stringency in order to group redundant terms and determine their
overall enrichment score [88].
Supporting Information
Figure S1 Pearson correlation between human ASC and
BMSC. Pearson correlation is 0.975 with a p-value ,0.0001,
calculated with Proc SAS as reported in Materials and Methods of
the main body of the paper. The correlation between each human
individual ranged from 0.954 to 0.963.
(TIF)
Figure S2 Number of cells before starting differentia-
tion and during the adipogenic and osteogenic differen-
tiation in porcine ASC and BMSC. The data were
normalized by log2 transformation prior analysis. The model
included time, cell type, differentiation and interactions: time6cell
type6differentiation; time6differentiation; time6cell type; cell
type6differentiation. Pig (n=3) was included as random variable.
A post-hoc correction using Tukey’s was applied. The time6cell
type6differentiation was significant at p=0.02 and all the main
effects and interactions were significant with exception of time.
Different letters denote p,0.05; * and # denote significant
(p,0.05) difference relative to dd0 in ASC during adipogenic
differentiation and BMSC during osteogenic differentiation,
respectively.
(TIF)
Figure S3 Significant enriched pathways between adi-
pogenic and osteogenic differentiation in ASC and
BMSC. Pathways from Ingenuity Pathway Analysis significantly
enriched (B–H-FDR #0.05) in at least one comparison among
DEG between adipogenic and osteogenic differentiation in ASC
(black line) and BMSC (red line). The lines and markers denote the
significance of enrichment in –log B–H-FDR (e.g., 0.05=1.33;
0.01=2.0) and cross symbols denote ratio of DEG/genes
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denotes a B–H FDR of 0.05 (-log B–H FDR of 1.33).
(TIF)
Figure S4 Quantity of RNA per cell (ng) before starting
differentiation and during the adipogenic and osteogen-
ic differentiation in porcine ASC and BMSC. The model
included time, cell type, differentiation and interactions: time6cell
type6differentiation; time6differentiation; time6cell type; cell
type6differentiation. Pig (n=3) was included as random variable.
A post-hoc correction using Tukey’s was applied. The time6cell
type6differentiation and overall differentiation were not signifi-
cant (p=0.81 and p=0.24, respectively); all the other main effects
and interactions were significant (p,0.05). * and # denote
significant (p,0.05) difference relative to dd0.
(TIF)
Figure S5 Significant enriched pathways between ASC
and BMSC during adipogenic and osteogenic differen-
tiation. Pathways from Ingenuity Pathway Analysis significantly
enriched (B–H-FDR #0.05) in at least one comparison among
DEG between ASC and BMSC during adipogenic (black line)
and osteogenic (red line) differentiation. The lines and markers
denote the significance of enrichment in –log B–H-FDR (e.g.,
0.05=1.33; 0.01=2.0) and cross symbols denote ratio of DEG/
genes composing the pathway (black adipogenic and red
osteogenic). The blue line denotes a B–H FDR of 0.05 (-log
B–H FDR of 1.33).
(TIF)
File S1 Supplementary Materials and Methods and
Results and Discussion.
(DOCX)
File S2 Entire microarray results during differentia-
tions plus qPCR and microarray comparison. The excel
file contains 4 sheets: ‘‘Cell type comparison’’ microarray
results of the direct comparison between ASC and BMSC during
both adipogenic and osteogenic differentiation; ‘‘Differentiation
comparison’’ microarray results of the direct comparison
between adipogenic and osteogenic differentiation in ASC and
BMSC; ‘‘qPCR vs Array adipogenic diff’’ comparison
between qPCR and microarray analysis for the adipogenic
differentiation; ‘‘qPCR vs Array osteogenic diff’’ comparison
between qPCR and microarray analysis for the osteogenic
differentiation.
(XLSX)
File S3 Results of functional analysis of genes highly
expressed in both MSC prior differentiation. The excel
sheet presents 6 sheets: ‘‘Sheet 1 -Transcripts .1,000 RFU’’
list of genes expressed with a Relative Fluorescence Units .1,000
($ to the signal of GAPDH) in our microarray; ‘‘Sheet 2 - Funct
chart .1000 RFU’’ functional chart analysis results from
DAVID of genes expressed with a Relative Fluorescence Units
.1,000; ‘‘Sheet 3-Funct cluster .1000 RFU’’ functional
cluster analysis results from DAVID of genes expressed with a
Relative Fluorescence Units .1,000; ‘‘Sheet 4 Funct chart
.10000RFU’’ functional chart analysis results from DAVID of
genes expressed with a Relative Fluorescence Units .10,000;
‘‘Sheet 5 Funct cluster .10000RFU’’ functional cluster analysis
results from DAVID of genes expressed with a Relative
Fluorescence Units .10,000; ‘‘Sheet 6 IPA Pathway
.10000RFU’’ depiction of the ‘‘Intrinsic Prothrombin Activation
Pathway’’ from Ingenuity Pathway Analysis.
(XLSX)
File S4 Results of functional analysis of genes more
expressed in both MSC prior to differentiation com-
pared to fully differentiated tissues. The excel file presents
11 sheets: ‘‘Sheet 1 MSC vs references’’ list of genes more
expressed in MSC vs. fully differentiated tissues; ‘‘Sheet 2 Funct
chart DEG.2fold’’ functional chart analysis results from
DAVID of genes expressed .2-fold in MSC vs. fully differentiated
tissues; ‘‘Sheet 3 Funct cluter DEG.2fold’’ functional cluster
analysis results from DAVID of genes expressed .2-fold in MSC
vs. fully differentiated tissues; ‘‘Sheet 4 IPA functions DEG.2-
fold’’ functional analysis results from Ingenuity Pathway Analysis
of genes expressed .2-fold in MSC vs. fully differentiated tissues;
‘‘Sheet 5 IPA effect funct .2fold’’ effect on function analysis
results from Ingenuity Pathway Analysis of genes expressed .2-
fold in MSC vs. fully differentiated tissues; ‘‘Sheet 6 IPA
pathways DEG.2fold’’ list and depiction of pathways signif-
icantly enriched (Benjamini-Hochberg P#0.05) in Ingenuity
Pathway Analysis of genes expressed .2-fold in MSC vs. fully
differentiated tissues; ‘‘Sheet 7 Funct chart DEG,0.5FD’’
functional chart analysis results from DAVID of genes expressed
#0.5-fold in MSC vs. fully differentiated tissues; ‘‘Sheet8 Funct
cluster DEG,0.5FD’’ functional cluster analysis results from
DAVID of genes expressed #0.5-fold in MSC vs. fully
differentiated tissues; ‘‘Sheet 9 IPA functions DEG,0.5FD’’
functional analysis results from Ingenuity Pathway Analysis of
genes expressed #0.5-fold in MSC vs. fully differentiated tissues;
‘‘Sheet 10 IPA eff func DEG,0.5FD’’ effect on function
analysis results from Ingenuity Pathway Analysis of genes
expressed #0.5-fold in MSC vs. fully differentiated tissues; ‘‘Sheet
11 IPA pathways DEG,0.5FD’’ list of pathways significantly
enriched (Benjamini-Hochberg P#0.05) in Ingenuity Pathway
Analysis of genes expressed #0.5-fold in MSC vs. fully
differentiated tissues.
(XLSX)
File S5 Results of functional analysis of genes differen-
tially expressed in BMSC and ASC prior differentiations.
The excel file contains 9 sheets: ‘‘Sheet 1 ASC vs BMSC
FDR0.05 p,0.001’’ complete list of DEG between BMSC and
ASC prior differentiation; ‘‘Sheet 2 Funct chart DEG.ASC’’
functional chart analysis results from DAVID of genes more
expressed in ASC vs. BMSC; ‘‘Sheet 3 Funct cluster
DEG.ASC’’ functional cluster analysis results from DAVID of
genes more expressed in ASC vs. BMSC; ‘‘Sheet 4 IPA Func
DEG.ASC vs BMSC’’ functional analysis results from Ingenuity
Pathway Analysis of genes more expressed in ASC vs. BMSC;
‘‘Sheet 5 Effect funct DEG.ASC’’ effect on function analysis
results from Ingenuity Pathway Analysis of genes more expressed
in ASC vs. BMSC; ‘‘Sheet 6 Funct chart DEG.BMSC’’
functional chart analysis results from DAVID of genes more
expressed in BMSC vs. ASC; ‘‘Sheet 7 Funct cluster
DEG.ASC’’ functional cluster analysis results from DAVID of
genes more expressed in BMSC vs. ASC; ‘‘Sheet 8 IPA Func
DEG.ASC vs BMSC’’ functional analysis results from Ingenuity
Pathway Analysis of genes more expressed in BMSC vs. ASC;
‘‘Sheet 9 Effect funct DEG.ASC’’ effect on function analysis
results from Ingenuity Pathway Analysis of genes more expressed
in BMSC vs. ASC.
(XLSX)
File S6 DAVID functional analysis results for genes
differentially expressed between adipogenesis and oste-
ogenesis in ASC and BMSC during differentiation. The
excel file contains 6 sheets: ‘‘Adipo vs Osteo ASC dd2’’
functional analysis results for both DEG more expressed in
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‘‘Adipo vs Osteo ASC dd7’’ functional analysis results for both
DEG more expressed in adipogenesis and more expressed in
osteogenesis for ASC at dd7; ‘‘Adipo vs Osteo ASC dd21’’
functional analysis results for both DEG more expressed in
adipogenesis and more expressed in osteogenesis for ASC at dd21;
‘‘Adipo vs Osteo BMSC dd2’’ functional analysis results for
both DEG more expressed in adipogenesis and more expressed in
osteogenesis for ASC at dd2; ‘‘Adipo vs Osteo BMSC dd7’’
functional analysis results for both DEG more expressed in
adipogenesis and more expressed in osteogenesis for BMSC at
dd7; ‘‘Adipo vs Osteo BMSC dd21’’ functional analysis results
for both DEG more expressed in adipogenesis and more expressed
in osteogenesis for BMSC at dd21.
(XLSX)
File S7 Results of significantly enriched pathway anal-
ysis from Ingenuity Pathway Analysis of DEG between
adipogenesis and osteogenesis and DEG between BMSC
and ASC during differentiation. The file contains the
complete list of enriched pathways (P-value #0.05) and figures
of the enriched pathways for each comparison.
(DOCX)
File S8 DAVID functional analysis results for genes
differentially expressed between ASC and BMSC during
adipogenic and osteogenic differentiation. The excel file
contains 6 sheets: ‘‘Sheet 1 Adipo BMSC vs ASC dd2’’
functional analysis results for both DEG more expressed in BMSC
and more expressed in ASC during adipogenesis at dd2; ‘‘Sheet 2
Adipo BMSC vs ASC dd7’’ functional analysis results for both
DEG more expressed in BMSC and more expressed in ASC
during adipogenesis at dd7; ‘‘Sheet 3 Adipo BMSC vs ASC
dd21’’ functional analysis results for both DEG more expressed in
BMSC and more expressed in ASC during adipogenesis at dd21;
‘‘Sheet 4 Osteo BMSC vs ASC dd2’’ functional analysis results
for both DEG more expressed in BMSC and more expressed in
ASC during osteogenesis at dd2; ‘‘Sheet 5 Osteo BMSC vs ASC
dd7’’ functional analysis results for both DEG more expressed in
BMSC and more expressed in ASC during osteogenesis at dd7;
‘‘Sheet 6 Osteo BMSC vs ASC dd21’’ functional analysis results
for both DEG more expressed in BMSC and more expressed in
ASC during osteogenesis at dd21.
(XLSX)
File S9 Functional analysis of DEG between BMSC and
ASC during the whole differentiation considering an
overall tissue effect with FDR #0.05. The excel file contains
14 sheets: ‘‘Sheet 1 DEG ASC vs BMSC FDR0.05’’ complete
list of DEG; ‘‘Sheet 2 Funct chart all FDR0.05’’ functional
chart analysis results from DAVID of DEG between ASC and
BMSC; ‘‘Sheet 3 Funct Clust all FDR0.05’’ functional cluster
analysis results from DAVID of DEG between ASC and BMSC;
‘‘Sheet 4 IPA func all FDR0.05’’ functional analysis results from
Ingenuity Pathway Analysis of DEG between ASC and BMSC;
‘‘Sheet 5 Effect func all FDR0.05’’ effect on function analysis of
functions significantly enriched in Ingenuity Pathway Analysis of
DEG between ASC and BMSC; ‘‘Sheet 6 IPA path all
FDR0.05’’ pathways analysis in Ingenuity Pathway Analysis of
DEG between ASC and BMSC; ‘‘Sheet 7 Funct chart
DEG.ASC’’ functional chart analysis results from DAVID of
DEG more expressed in ASC vs. BMSC; ‘‘Sheet 8 Funct cluster
DEG.ASC’’ functional cluster analysis results from DAVID of
DEG more expressed in ASC vs. BMSC; ‘‘Sheet 9 IPA Func
DEG.ASC vs BMSC’’ functional analysis results from Ingenuity
Pathway Analysis of DEG more expressed in ASC vs. BMSC;
‘‘Sheet 10 Effect funct DEG.ASC’’ effect on function analysis
of functions significantly enriched in Ingenuity Pathway Analysis
of DEG more expressed in ASC vs. BMSC; ‘‘Sheet 11 IPA Path
DEG.ASC vs BMSC’’ pathways analysis results from Ingenuity
Pathway Analysis of DEG more expressed in ASC vs. BMSC;
‘‘Sheet 12 Funct chart DEG.BMSC’’ functional chart analysis
results from DAVID of DEG more expressed in BMSC vs. ASC;
‘‘Sheet 13 Funct cluster DEG.BMSC’’ functional cluster
analysis results from DAVID of DEG more expressed in BMSC vs.
ASC; ‘‘Sheet 14 IPA Path DEG.BMSCvASC’’ functional
analysis results from Ingenuity Pathway Analysis of DEG more
expressed in BMSC vs. ASC.
(XLSX)
File S10 Complete list of markers for osteogenic and
adipogenic differentiation with relative functional anal-
ysis. The excel file contains 15 sheets: ‘‘Sheet1 Markers’’
complete list of markers; ‘‘Sheet2 David adipog markers’’
functional analysis of overall adipogenic markers; ‘‘Sheet3 David
osteog markers’’ functional analysis of overall osteogenic
markers; ‘‘Sheet4 David adipog markers ASC’’ functional
analysis of adipogenic markers in ASC; ‘‘Sheet5 David osteog
markers ASC’’ functional analysis of osteogenic markers in ASC;
‘‘Sheet6 David adipog marker BMSC’’ functional analysis of
adipogenic markers in BMSC; ‘‘Sheet7 David osteog marker
BMSC’’ functional analysis of osteogenic markers in BMSC;
‘‘Sheet8 David adipog markers 2dd’’ functional analysis of
adipogenic markers at dd2; ‘‘Sheet9 David adipog markers
7dd’’ functional analysis of adipogenic markers at dd7; ‘‘Sheet10
David adipog markers 21dd’’ functional analysis of adipogenic
markers at dd21; ‘‘Sheet11 David adipog mark 7–21dd’’
functional analysis of adipogenic markers between 7 and 21 day of
differentiation; ‘‘Sheet12 David osteog marker 2dd’’ func-
tional analysis of osteogenic markers at dd2; ‘‘Sheet13 David
osteog marker 7dd’’ functional analysis of osteogenic markers at
dd7; ‘‘Sheet14 David osteog mark 21dd’’ functional analysis of
osteogenic markers at dd21; ‘‘Sheet15 David osteog mark 7–
21dd’’ functional analysis of osteogenic markers between 7 and 21
day of differentiation.
(XLSX)
File S11 Functional chart analysis from DAVID of the
entire annotated microarray used in the present exper-
iment (excel file with only 1 sheet).
(XLSX)
Table S1 Pearson correlation between ASC and BMSC
transcriptome. Reported are the results from SAS analysis of
overall Pearson correlation between ASC and BMSC transcrip-
tome overall, before differentiation (dd0) for all the pigs and for
each single pig; between differentiations in the same cell type (ASC
or BMSC) overall and for each single pig; and overall correlation
between ASC and BMSC during adipogenic and osteogenic
differentiation. All correlations were significant at p,0.0001.
(DOCX)
Table S2 Functional analysis results by IPA of adipo-
genic and osteogenic differentiation of ASC at dd2.
Tabulated results from Ingenuity Pathway AnalysisH (IPA) effect
on function analysis of DEG between adipogenic and osteogenic
differentiation of ASC at dd2. Reported are the functions sorted
by decrease in significance. The category denotes the main
functional category assigned by IPA. The function annotation is
derived by the ‘‘effect on function’’ in IPA. In parenthesis are
reported the number of DEG for each specific function and the
arrows denote the overall effect on the function inferred by the
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PLoS ONE | www.plosone.org 16 March 2012 | Volume 7 | Issue 3 | e32481gene annotation using IPA (XX=highly activated in adipogenic vs.
osteogenic differentiation; X=activated in adipogenic vs. osteo-
genic differentiation; q=tends to be activated in adipogenic vs.
osteogenic differentiation; YY=highly activated in osteogenic vs.
adipogenic differentiation; Y=activated in osteogenic vs. adipo-
genic differentiation; Q=tends to be activated in osteogenic vs.
adipogenic differentiation) following the criteria reported in
Materials and Methods in file S1. In yellow shade all functions
enriched with a B–H FDR#0.05.
(DOCX)
Table S3 Functional analysis results by IPA of adipo-
genic and osteogenic differentiation of ASC at dd21.
Tabulated results from Ingenuity Pathway AnalysisH (IPA) effect
on function analysis of DEG between adipogenic and osteogenic
differentiation of ASC at dd21. Reported are the functions sorted
by decrease in significance. The category denotes the main
functional category assigned by IPA. The function annotation is
derived by the ‘‘effect on function’’ in IPA. In parenthesis are
reported the number of DEG for each specific function and the
arrows denote the overall effect on the function inferred by the
gene annotation using IPA (XX=highly activated in adipogenic vs.
osteogenic differentiation; X=activated in adipogenic vs. osteo-
genic differentiation; q=tends to be activated in adipogenic vs.
osteogenic differentiation; YY=highly activated in osteogenic vs.
adipogenic differentiation; Y=activated in osteogenic vs. adipo-
genic differentiation; Q=tends to be activated in osteogenic vs.
adipogenic differentiation.) following the criteria reported in
Materials and Methods in file S1.
(DOCX)
Table S4 Function analysis results by IPA of adipogenic
and osteogenic differentiation of BMSC at dd21. Tabu-
lated results from Ingenuity Pathway AnalysisH (IPA) effect on
function analysis of DEG between adipogenic and osteogenic
differentiation of BMSC at dd21. Reported are the functions
sorted by decrease in significance. The category denotes the main
functional category assigned by IPA. The function annotation is
derived by the ‘‘effect on function’’ in IPA. In parenthesis are
reported the number of DEG for each specific function and the
arrows denote the overall effect on the function inferred by the
gene annotation using IPA (XX=highly activated in adipogenic vs.
osteogenic differentiation; X=activated in adipogenic vs. osteo-
genic differentiation; q=tends to be activated in adipogenic vs.
osteogenic differentiation; YY=highly activated in osteogenic vs.
adipogenic differentiation; Y=activated in osteogenic vs. adipo-
genic differentiation; Q=tends to be activated in osteogenic vs.
adipogenic differentiation) following the criteria reported in
Materials and Methods in file S1.
(DOCX)
Table S5 Pearson correlation between ASC and BMSC
transcriptome in each pig and for each time point
during adipogenic and osteogenic differentiation. All
correlations were significant at p,0.0001.
(DOCX)
Table S6 Pearson correlation between pigs (12, 22, and
40) transcriptome in each cell type (ASC or BMSC)
during adipogenic and osteogenic differentiation. All
correlations were significant at p,0.0001.
(DOCX)
Table S7 Function analysis results by IPA of BMSC and
ASC during adipogenic differentiation at dd2. Tabulated
results from Ingenuity Pathway AnalysisH (IPA) effect on function
analysis of DEG between BMSC and ASC during adipogenic
differentiation at dd2. Reported are the functions sorted by
decrease in significance. The category denotes the main functional
category assigned by IPA. The function annotation is derived by
the ‘‘effect on function’’ in IPA. In parenthesis are reported the
number of DEG for each specific function and the arrows denote
the overall effect on the function inferred by the gene annotation
using IPA (XX=highly activated in BMSC vs. ASC; X=activated
in BMSC vs. ASC; q=tends to be activated in BMSC vs. ASC;
YY=highly activated in ASC vs. BMSC; Y=activated in ASC vs.
BMSC; Q=tends to be activated in ASC vs. BMSC) following the
criteria reported in Materials and Methods in file S1. Effect on
functions with ,2 genes were discarded.
(DOCX)
Table S8 Function analysis results by IPA of BMSC and
ASC during adipogenic differentiation at dd7. Tabulated
results from Ingenuity Pathway AnalysisH (IPA) effect on function
analysis of DEG between BMSC and ASC during adipogenic
differentiation at dd7. Reported are the functions sorted by
decrease in significance. The category denotes the main functional
category assigned by IPA. The function annotation is derived by
the ‘‘effect on function’’ in IPA. In parenthesis are reported the
number of DEG for each specific function and the arrows denote
the overall effect on the function inferred by the gene annotation
using IPA (XX=highly activated in BMSC vs. ASC; X=activated
in BMSC vs. ASC; q=tends to be activated in BMSC vs. ASC;
YY=highly activated in ASC vs. BMSC; Y=activated in ASC vs.
BMSC; Q=tends to be activated in ASC vs. BMSC) following the
criteria reported in Materials and Methods in file S1. Effect on
functions with ,2 genes were discarded.
(DOCX)
Table S9 Functional analysis results by IPA of BMSC
and ASC during adipogenic differentiation at dd21.
Tabulated results from Ingenuity Pathway AnalysisH (IPA) effect
on function analysis of DEG between BMSC and ASC during
adipogenic differentiation at dd21. Reported are the functions
sorted by decrease in significance. The category denotes the main
functional category assigned by IPA. The function annotation is
derived by the ‘‘effect on function’’ in IPA. In parenthesis are
reported the number of DEG for each specific function and the
arrows denote the overall effect on the function inferred by the
gene annotation using IPA (XX=highly activated in BMSC vs.
ASC; X=activated in BMSC vs. ASC; q=tends to be activated
in BMSC vs. ASC; YY=highly activated in ASC vs. BMSC;
Y=activated in ASC vs. BMSC; Q=tends to be activated in ASC
vs. BMSC) following the criteria reported in Materials and
Methods in file S1. Effect on functions with ,2 genes were
discarded.
(DOCX)
Table S10 Functional analysis results by IPA of BMSC
and ASC during osteogenic differentiation at dd2.
Tabulated results from Ingenuity Pathway AnalysisH (IPA) effect
on function analysis of DEG between BMSC and ASC during
osteogenic differentiation at dd2. Reported are the functions
sorted by decrease in significance. The category denotes the main
functional category assigned by IPA. The function annotation is
derived by the ‘‘effect on function’’ in IPA. In parenthesis are
reported the number of DEG for each specific function and the
arrows denote the overall effect on the function inferred by the
gene annotation using IPA (XX=highly activated in BMSC vs.
ASC; X=activated in BMSC vs. ASC; q=tends to be activated
in BMSC vs. ASC; YY=highly activated in ASC vs. BMSC;
Y=activated in ASC vs. BMSC; Q=tends to be activated in ASC
vs. BMSC) following the criteria reported in Materials and
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discarded.
(DOCX)
Table S11 Functional analysis results by IPA of BMSC
and ASC during osteogenic differentiation at dd21.
Reported are the functions sorted by decrease in significance.
The function annotation is derived by the ‘‘effect on function’’ in
IPA. In parenthesis are reported the number of DEG for each
specific function and the arrows denote the overall effect on the
function inferred by the gene annotation using IPA (XX=highly
activated in BMSC vs. ASC; X=activated in BMSC vs. ASC;
q=tends to be activated in BMSC vs. ASC; YY=highly activated
in ASC vs. BMSC; Y=activated in ASC vs. BMSC; Q=tends to
be activated in ASC vs. BMSC) following the criteria reported in
Materials and Methods in file S1. Effect on functions with ,2
genes were discarded.
(DOCX)
Video S1 ASC Adipogenesis 1. The video is a time lapse
taken for 12 h after addition of adipogenic medium in ASC
(replicate 1) cultivated in 24 well plate (2 frames/s; pictures were
taken every 20 min).
(FLV)
Video S2 ASC Adipogenesis 2. The video is a time lapse
taken for 12 h after addition of adipogenic medium in ASC
(replicate 2) cultivated in 24 well plate (2 frames/s; pictures were
taken every 20 min).
(FLV)
Video S3 ASC Osteogenesis 1. The video is a time lapse
taken for 12 h after addition of osteogenic medium in ASC
(replicate 1) cultivated in 24 well plate (2 frames/s; pictures were
taken every 20 min).
(FLV)
Video S4 ASC Osteogenesis 2. The video is a time lapse
taken for 12 h after addition of osteogenic medium in ASC
(replicate 2) cultivated in 24 well plate (2 frames/s; pictures were
taken every 20 min).
(FLV)
Acknowledgments
The authors acknowledge Dr. Juan J Loor at the Nutriphysiogenomics lab
in the Animal Science Department at the University of Illinois for having
provided the lab and protocol for microarray analysis; Dr. Robin E. Everts
for annotating the porcine microarray.
Author Contributions
Conceived and designed the experiments: MBW WLH. Performed the
experiments: EM MB MBW. Analyzed the data: EM MB SRZ MBW.
Contributed reagents/materials/analysis tools: MBW SRZ. Wrote the
paper: EM MB MBW. Critically revised the paper: SRZ WLH MBW.
References
1. Slynarski K, Deszczynski J, Karpinski J (2006) Fresh bone marrow and
periosteum transplantation for cartilage defects of the knee. Transplant Proc 38:
318–319.
2. Veyrat-Masson R, Boiret-Dupre N, Rapatel C, Descamps S, Guillouard L, et al.
(2007) Mesenchymal content of fresh bone marrow: a proposed quality control
method for cell therapy. Br J Haematol 139: 312–320.
3. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA (2009) Mesenchymal stem
cells: immunobiology and role in immunomodulation and tissue regeneration.
Cytotherapy 11: 377–391.
4. Meirelles Lda S, Fontes AM, Covas DT, Caplan AI (2009) Mechanisms involved
in the therapeutic properties of mesenchymal stem cells. Cytokine Growth
Factor Rev 20: 419–427.
5. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O (2003) HLA
expression and immunologic properties of differentiated and undifferentiated
mesenchymal stem cells. Exp Hematol 31: 890–896.
6. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, et al. (2002)
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong
skin graft survival in vivo. Exp Hematol 30: 42–48.
7. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC (2003) Suppression
of allogeneic T-cell proliferation by human marrow stromal cells: implications in
transplantation. Transplantation 75: 389–397.
8. Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of
fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen
cells. Cell Tissue Kinet 3: 393–403.
9. Fraser JK, Wulur I, Alfonso Z, Hedrick MH (2006) Fat tissue: an
underappreciated source of stem cells for biotechnology. Trends Biotechnol
24: 150–154.
10. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells
from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:
211–228.
11. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, et al. (2002) Human
adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279–4295.
12. Dong XH, Lei YH, Fu XB, Wang WL, Sun TZ, et al. (2007) [Identification and
cell phenotype transdifferentiation of adipose-derived stem cells]. Zhonghua
Zheng Xing Wai Ke Za Zhi 23: 151–153.
13. Hattori H, Sato M, Masuoka K, Ishihara M, Kikuchi T, et al. (2004) Osteogenic
potential of human adipose tissue-derived stromal cells as an alternative stem cell
source. Cells Tissues Organs 178: 2–12.
14. Jurgens WJ, Oedayrajsingh-Varma MJ, Helder MN, Zandiehdoulabi B,
Schouten TE, et al. (2008) Effect of tissue-harvesting site on yield of stem cells
derived from adipose tissue: implications for cell-based therapies. Cell Tissue Res
332: 415–426.
15. Oedayrajsingh-Varma MJ, van Ham SM, Knippenberg M, Helder MN, Klein-
Nulend J, et al. (2006) Adipose tissue-derived mesenchymal stem cell yield and
growth characteristics are affected by the tissue-harvesting procedure.
Cytotherapy 8: 166–177.
16. Phillips RW, Tumbleson ME (1986) Swine in biomedical research. In:
Tumbleson ME, ed. Models. New York, N.Y.: Plenum Press.
17. Kim D, Monaco E, Maki A, de Lima AS, Kong HJ, et al. (2010) Morphologic
and transcriptomic comparison of adipose- and bone-marrow-derived
porcine stem cells cultured in alginate hydrogels. Cell Tissue Res 341: 359–
370.
18. Monaco E, Sobreira de Lima A, Bionaz M, Maki AJ, Wilson SW, et al. (2009)
Morphological and Transcriptomic Comparison of Adipose and Bone Marrow
Derived Porcine Stem Cells. The Open Tissue Engineering & Regenerative
Medicine Journal. pp 20–33.
19. Noel D, Caton D, Roche S, Bony C, Lehmann S, et al. (2008) Cell specific
differences between human adipose-derived and mesenchymal-stromal cells
despite similar differentiation potentials. Experimental Cell Research 314:
1575–1584.
20. Rada T, Reis RL, Gomes ME (2009) Adipose tissue-derived stem cells and their
application in bone and cartilage tissue engineering. Tissue Eng Part B Rev 15:
113–125.
21. Lin CS, Xin ZC, Deng CH, Ning H, Lin G, et al. (2010) Defining adipose
tissue-derived stem cells in tissue and in culture. Histol Histopathol 25: 807–
815.
22. Jansen BJ, Gilissen C, Roelofs H, Schaap-Oziemlak A, Veltman JA, et al. (2010)
Functional differences between mesenchymal stem cell populations are reflected
by their transcriptome. Stem Cells Dev 19: 481–490.
23. Burns JS, Rasmussen PL, Larsen KH, Schroder HD, Kassem M (2010)
Parameters in three-dimensional osteospheroids of telomerized human mesen-
chymal (stromal) stem cells grown on osteoconductive scaffolds that predict in
vivo bone-forming potential. Tissue Eng Part A 16: 2331–2342.
24. Hergeth SP, Aicher WK, Essl M, Schreiber TD, Sasaki T, et al. (2008)
Characterization and functional analysis of osteoblast-derived fibulins in the
human hematopoietic stem cell niche. Exp Hematol 36: 1022–1034.
25. Ruan K, Bao S, Ouyang G (2009) The multifaceted role of periostin in
tumorigenesis. Cell Mol Life Sci 66: 2219–2230.
26. Yamamura S, Kawakami K, Hirata H, Ueno K, Saini S, et al. (2010) Oncogenic
functions of secreted Frizzled-related protein 2 in human renal cancer. Mol
Cancer Ther 9: 1680–1687.
27. Bodine PV, Komm BS (2006) Wnt signaling and osteoblastogenesis. Rev Endocr
Metab Disord 7: 33–39.
28. Butler WT (1989) The nature and significance of osteopontin. Connect Tissue
Res 23: 123–136.
29. Spiryda LB (1998) Myelin protein zero and membrane adhesion. J Neurosci Res
54: 137–146.
30. Liau SS, Rocha F, Matros E, Redston M, Whang E (2008) High mobility group
AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic
target in pancreatic adenocarcinoma. Cancer 113: 302–314.
31. Hirashima M (2009) Regulation of endothelial cell differentiation and arterial
specification by VEGF and Notch signaling. Anat Sci Int 84: 95–101.
Porcine ASC and BMSC Transcriptomics
PLoS ONE | www.plosone.org 18 March 2012 | Volume 7 | Issue 3 | e324813 2 .O g u r aN ,K a w a d aM ,C h a n gW J ,Z h a n gQ ,L e eS Y ,e ta l .( 2 0 0 4 )
Differentiation of the human mesenchymal stem cells derived from bone
marrow and enhancement of cell attachment by fibronectin. J Oral Sci 46:
207–213.
33. Christiaens V, Lijnen HR (2010) Angiogenesis and development of adipose
tissue. Mol Cell Endocrinol 318: 2–9.
34. Zhang K, Shi B, Chen J, Zhang D, Zhu Y, et al. (2010) Bone marrow
mesenchymal stem cells induce angiogenesis and promote bladder cancer
growth in a rabbit model. Urol Int 84: 94–99.
35. Huang da W, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment
tools: paths toward the comprehensive functional analysis of large gene lists.
Nucleic Acids Res 37: 1–13.
36. Huang da W, Sherman BT, Zheng X, Yang J, Imamichi T, et al. (2009)
Extracting biological meaning from large gene lists with DAVID. Curr Protoc
Bioinformatics Chapter 13: Unit 13 11.
37. Dinser R, Pelled G, Muller-Ladner U, Gazit D, Neumann E (2009) Expression
of Brachyury in mesenchymal progenitor cells leads to cartilage-like tissue that is
resistant to the destructive effect of rheumatoid arthritis synovial fibroblasts.
J Tissue Eng Regen Med 3: 124–128.
38. Chang Y, Ostling P, Akerfelt M, Trouillet D, Rallu M, et al. (2006) Role of heat-
shock factor 2 in cerebral cortex formation and as a regulator of p35 expression.
Genes Dev 20: 836–847.
39. Kallio M, Chang Y, Manuel M, Alastalo TP, Rallu M, et al. (2002) Brain
abnormalities, defective meiotic chromosome synapsis and female subfertility in
HSF2 null mice. EMBO J 21: 2591–2601.
40. Peng H, Ivanov AV, Oh HJ, Lau YF, Rauscher FJ, 3rd (2009) Epigenetic gene
silencing by the SRY protein is mediated by a KRAB-O protein that recruits the
KAP1 co-repressor machinery. J Biol Chem 284: 35670–35680.
41. Krawczyk M, Peyraud N, Rybtsova N, Masternak K, Bucher P, et al. (2004)
Long distance control of MHC class II expression by multiple distal enhancers
regulated by regulatory factor X complex and CIITA. J Immunol 173:
6200–6210.
42. Kistler WS, Horvath GC, Dasgupta A, Kistler MK (2009) Differential
expression of Rfx1–4 during mouse spermatogenesis. Gene Expr Patterns 9:
515–519.
43. Hsu YC, Liao WC, Kao CY, Chiu IM (2010) Regulation of FGF1 gene
promoter through transcription factor RFX1. J Biol Chem 285: 13885–13895.
44. Lin CS, Xin ZC, Deng CH, Ning H, Lin G, et al. (2008) Recent advances in
andrology-related stem cell research. Asian J Androl 10: 171–175.
45. Koga H, Engebretsen L, Brinchmann JE, Muneta T, Sekiya I (2009)
Mesenchymal stem cell-based therapy for cartilage repair: a review. Knee Surg
Sports Traumatol Arthrosc 17: 1289–1297.
46. Zavan B, Michelotto L, Lancerotto L, Della Puppa A, D’Avella D, et al. (2010)
Neural potential of a stem cell population in the adipose and cutaneous tissues.
Neurol Res 32: 47–54.
47. Sadan O, Melamed E, Offen D (2009) Bone-marrow-derived mesenchymal stem
cell therapy for neurodegenerative diseases. Expert Opin Biol Ther 9:
1487–1497.
48. Arakawa H, Nakamura T, Zhadanov AB, Fidanza V, Yano T, et al. (1998)
Identification and characterization of the ARP1 gene, a target for the human
acute leukemia ALL1 gene. Proc Natl Acad Sci U S A 95: 4573–4578.
49. Jochheim-Richter A, Rudrich U, Koczan D, Hillemann T, Tewes S, et al. (2006)
Gene expression analysis identifies novel genes participating in early murine liver
development and adult liver regeneration. Differentiation 74: 167–173.
50. Smidt MP, Cox JJ, van Schaick HS, Coolen M, Schepers J, et al. (2000) Analysis
of three Ptx2 splice variants on transcriptional activity and differential expression
pattern in the brain. J Neurochem 75: 1818–1825.
51. Lamba P, Hjalt TA, Bernard DJ (2008) Novel forms of Paired-like
homeodomain transcription factor 2 (PITX2): generation by alternative
translation initiation and mRNA splicing. BMC Mol Biol 9: 31.
52. Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, et al. (2004)
Plasticity of human adipose lineage cells toward endothelial cells: physiological
and therapeutic perspectives. Circulation 109: 656–663.
53. Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, et al. (2004)
Improvement of postnatal neovascularization by human adipose tissue-derived
stem cells. Circulation 110: 349–355.
54. Hausman GJ, Richardson RL (2004) Adipose tissue angiogenesis. J Anim Sci 82:
925–934.
55. Larrodera P, Cornet ME, Diaz-Meco MT, Lopez-Barahona M, Diaz-Laviada I,
et al. (1990) Phospholipase C-mediated hydrolysis of phosphatidylcholine is an
important step in PDGF-stimulated DNA synthesis. Cell 61: 1113–1120.
56. Frayn KN (2010) Fat as a fuel: emerging understanding of the adipose tissue-
skeletal muscle axis. Acta Physiol (Oxf) 199: 509–518.
57. Vartak N, Bastiaens P (2010) Spatial cycles in G-protein crowd control. EMBO J
29: 2689–2699.
58. Park JG, Muise A, He GP, Kim SW, Ro HS (1999) Transcriptional regulation
by the gamma5 subunit of a heterotrimeric G protein during adipogenesis.
EMBO J 18: 4004–4012.
59. Lamkhioued B, Abdelilah SG, Hamid Q, Mansour N, Delespesse G, et al. (2003)
The CCR3 receptor is involved in eosinophil differentiation and is up-regulated
by Th2 cytokines in CD34+ progenitor cells. J Immunol 170: 537–547.
60. Bonaros N, Hennerbichler D, Friedrich G, Kocher A, Pachinger O, et al. (2009)
Increased mortality and perioperative complications in patients with previous
elective percutaneous coronary interventions undergoing coronary artery bypass
surgery. J Thorac Cardiovasc Surg 137: 846–852.
61. Liang SX, Tan TY, Gaudry L, Chong B (2010) Differentiation and migration of
Sca1+/CD312 cardiac side population cells in a murine myocardial ischemic
model. Int J Cardiol 138: 40–49.
62. Lapidot T, Kollet O (2002) The essential roles of the chemokine SDF-1 and its
receptor CXCR4 in human stem cell homing and repopulation of transplanted
immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia
16: 1992–2003.
63. Pusic I, Dipersio JF (2010) Update on clinical experience with AMD3100, an
SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and
progenitor cells. Curr Opin Hematol.
64. Cho HH, Kyoung KM, Seo MJ, Kim YJ, Bae YC, et al. (2006) Overexpression
of CXCR4 increases migration and proliferation of human adipose tissue
stromal cells. Stem Cells Dev 15: 853–864.
65. Sengenes C, Miranville A, Maumus M, de Barros S, Busse R, et al. (2007)
Chemotaxis and differentiation of human adipose tissue CD34+/CD312
progenitor cells: role of stromal derived factor-1 released by adipose tissue
capillary endothelial cells. Stem Cells 25: 2269–2276.
66. Pasquale EB (2005) Eph receptor signalling casts a wide net on cell behaviour.
Nat Rev Mol Cell Biol 6: 462–475.
67. Edwards CM, Mundy GR (2008) Eph receptors and ephrin signaling pathways:
a role in bone homeostasis. Int J Med Sci 5: 263–272.
68. Viswanathan A, Painter RG, Lanson NA, Jr., Wang G (2007) Functional
expression of N-formyl peptide receptors in human bone marrow-derived
mesenchymal stem cells. Stem Cells 25: 1263–1269.
69. Spiegelman BM, Hu E, Kim JB, Brun R (1997) PPAR gamma and the control of
adipogenesis. Biochimie 79: 111–112.
70. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, et al. (2004) PPAR
gamma insufficiency enhances osteogenesis through osteoblast formation from
bone marrow progenitors. Journal of Clinical Investigation 113: 846–855.
71. Guo X, Liu L, Zhang M, Bergeron A, Cui Z, et al. (2009) Correlation of CD34+
cells with tissue angiogenesis after traumatic brain injury in a rat model.
J Neurotrauma 26: 1337–1344.
72. Tse HF, Yiu KH, Lau CP (2007) Bone marrow stem cell therapy for myocardial
angiogenesis. Curr Vasc Pharmacol 5: 103–112.
73. Langer DA, Shah VH (2006) Nitric oxide and portal hypertension: interface of
vasoreactivity and angiogenesis. J Hepatol 44: 209–216.
74. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, et al. (2008) Mesenchymal stem cell-
mediated immunosuppression occurs via concerted action of chemokines and
nitric oxide. Cell Stem Cell 2: 141–150.
75. Hall B, Dembinski J, Sasser AK, Studeny M, Andreeff M, et al. (2007)
Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based
delivery vehicles. Int J Hematol 86: 8–16.
76. Li L, Tian H, Yue W, Zhu F, Li S, et al. (2010) Human mesenchymal stem cells
play a dual role on tumor cell growth in vitro and in vivo. J Cell Physiol.
77. Yu JM, Jun ES, Bae YC, Jung JS (2008) Mesenchymal stem cells derived from
human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev 17:
463–473.
78. Funderburgh JL (2002) Keratan sulfate biosynthesis. IUBMB Life 54: 187–194.
79. Voog J, Jones DL (2010) Stem cells and the niche: a dynamic duo. Cell Stem
Cell 6: 103–115.
80. Lapi S, Nocchi F, Lamanna R, Passeri S, Iorio M, et al. (2008) Different media
and supplements modulate the clonogenic and expansion properties of rabbit
bone marrow mesenchymal stem cells. BMC Res Notes 1: 53.
81. Draghici S, Khatri P, Tarca AL, Amin K, Done A, et al. (2007) A systems
biology approach for pathway level analysis. Genome Res 17: 1537–1545.
82. Loor JJ, Dann HM, Everts RE, Oliveira R, Green CA, et al. (2005) Temporal
gene expression profiling of liver from periparturient dairy cows reveals complex
adaptive mechanisms in hepatic function. Physiol Genomics 23: 217–226.
83. Zhao SH, Recknor J, Lunney JK, Nettleton D, Kuhar D, et al. (2005) Validation
of a first-generation long-oligonucleotide microarray for transcriptional profiling
in the pig. Genomics 86: 618–625.
84. Loor JJ, Everts RE, Bionaz M, Dann HM, Morin DE, et al. (2007) Nutrition-
induced ketosis alters metabolic and signaling gene networks in liver of
periparturient dairy cows. Physiol Genomics 32: 105–116.
85. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate - a
Practical and Powerful Approach to Multiple Testing. Journal of the Royal
Statistical Society Series B-Methodological 57: 289–300.
86. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative
analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:
44–57.
87. Piantoni P, Bionaz M, Graugnard DE, Daniels KM, Everts RE, et al. (2010)
Functional and gene network analyses of transcriptional signatures character-
izing pre-weaned bovine mammary parenchyma or fat pad uncovered novel
inter-tissue signaling networks during development. BMC Genomics 11: 331.
88. Huang da W, Sherman BT, Tan Q, Kir J, Liu D, et al. (2007) DAVID
Bioinformatics Resources: expanded annotation database and novel algorithms
to better extract biology from large gene lists. Nucleic Acids Res 35: W169–175.
Porcine ASC and BMSC Transcriptomics
PLoS ONE | www.plosone.org 19 March 2012 | Volume 7 | Issue 3 | e32481